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ABSTRACT (ENGLISH) 
The core symptoms of children with attention deficit hyperactivity disorder (ADHD) are 
inattention, hyperactivity, and impulsivity (American Psychiatric Association, 2000). A 
primary deficit in inhibitory control is proposed to account for dysfunctional behavior 
patterns associated with this disorder (Barkley, 1997). Early research has shown that 
medication (e.g., Methylphenidate) is effective when it comes to enhancing inhibitory 
control (e.g., Pliszka et al., 2007). Therefore, by incorporating relevant results from the 
previous study (Paul-Jordanov, Bechtold, & Gawrilow, 2010)
1
, we explored the effect of 
medication on inhibition in children with ADHD in Germany and Taiwan at the same time. 
Children with ADHD and normally developing children in Germany and Taiwan were 
recruited for the current studies. In Study 1, using a Go/NoGo task, we investigated the 
response inhibition of children with ADHD and their healthy counterparts at both sites. 
Significantly, children with ADHD in Germany showed deficits in response inhibition 
compared to their healthy counterparts. A group difference, however, was not pronouncedly 
observed in the Taiwanese sample. In Study 2, the effect of medication on response 
inhibition was explored in children with ADHD. After the treatment of medication, the 
response inhibition in the ADHD group in Germany was ameliorated, while the effect of 
medication did not reach any significance in the Taiwanese sample. Results and 
implications for future studies are discussed. 
 
Keywords: attention deficit hyperactivity disorder, cross-cultural study, executive functions, 
medication, response inhibition 
 
                                                          
1
 Relevant results from the previous study (Paul-Jordanov, Bechtold, & Gawrilow, 2010) are included in the 
current research with author’s permission. 
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ABSTRACT (GERMAN) 
Die Kernsymptome von Kindern mit einer Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung 
(ADHS) sind Unaufmerksamkeit, Hyperaktivität und Impulsivität (American Psychiatric 
Association, 2000). Es wird vermutet, dass ein Kerndefizit an inhibitorischer Kontrolle, das 
in Verbindung mit dieser Störung steht, ursächlich ist für das dysfunktionale Verhalten 
(Barkley, 1997). Die frühe Forschung hat gezeigt, dass mit Medikamenten (z.B. 
Methylphenidat) positiv auf die inhibitorische Kontrolle eingewirkt werden kann (z.B. 
Pliszka et al., 2007). Daher wurde, unter Einbeziehung der einschlägigen Ergebnisse aus der 
vorangegangenen Studie
2
 (Paul-Jordanov, Bechtold & Gawrilow, 2010), die hemmende 
Wirkung von Medikamenten bei Kindern mit ADHS untersucht, und zwar in Deutschland 
und in Taiwan parallel. An der aktuellen Studie nahmen sowohl Kinder mit ADHS als auch 
normal entwickelte Kinder (Kontrollgruppe) teil. In Studie 1 untersuchten wir mit einem 
Go/NoGo-Task die Handlungsinhibition von Kindern mit ADHS und der Kontrollgruppe an 
beiden Standorten. Deutlich wurden hierbei die Defizite in der Handlungsinhibition bei mit 
ADHS diagnostizierten Kindern in Deutschland im Vergleich zu den gesunden Kindern. 
Die Probanden in Taiwan wiesen diesbezüglich dagegen keinen so deutlichen Unterschied 
auf. In Studie 2 wurde die Wirkung der Medikamente auf die Handlungsinhibition bei 
Kindern mit ADHS untersucht. Nach der Behandlung der Medikamente wurde die 
Handlungsinhibition der ADHS-Gruppe in Deutschland gemildert, während der Effekt bei 
den Probanden in Taiwan nicht die gleiche Bedeutung erreichte. Ergebnisse und 
Implikationen für zukünftige Studien werden diskutiert. 
 
Schlüsselwörter: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung, exekutive Funktionen, 
Handlungsinhibition, interkulturelle Studie, Medikamente 
                                                          
2
 Relevante Ergebnisse aus der vorangegangenen Studie (Paul-Jordanov, Bechtold, & Gawrilow, 2010) 
werden in der aktuellen Forschung mit Erlaubnis des Autors herangezogen. 
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1. Introduction 
Children with attention deficit hyperactivity disorder (ADHD) are impulsive and 
have difficulty regulating their behaviors in everyday life (Nigg, 2001; Reid, Trout, & 
Schartz, 2005), which may arise from poor inhibitory control (Barkley, 1997). Thus, they 
perform more poorly than do non-ADHD children on the Go/NoGo task, a task that requires 
a response to one type of stimulus but the withdrawal of a prepotent response to another 
type of stimulus. Earlier studies have pointed to ADHD symptoms as persisting in most 
clinically diagnosed children into their adolescence (Barkley, 2004; Gau, Chiu, Shang, 
Cheng, & Soong, 2009). 
Methylphenidate (MPH) is the most commonly prescribed and widely discussed 
stimulant medication regarding the treatment of ADHD symptoms (Goldman, Genel, 
Bezman, & Slanetz, 1998). MPH is effective in ameliorating relevant symptom severity 
(e.g., Jensen, 2009). Children with ADHD can also benefit from MPH on inhibitory control 
as measured by inhibition tasks, which has been demonstrated in several behavioral, 
electrophysiological, and neuroimaging studies (e.g., Broyd et al., 2005; Hart, Radua, 
Nakao, Mataix-Cols, & Rubia, 2013). 
Inhibitory control is a developmental pattern; Wanless et al. (2011) noted, 
―…patterns of development are contextually specific and a skill such as behavioral 
regulation must be examined within each society in order to understand its unique properties 
and meaning (Cole, 1996; Shweder et al., 1998)‖ (p.366). Therefore, in the current research, 
by revisiting and incorporating the relevant results from the prior research (Paul-Jordanov, 
Bechtold, & Gawrilow, 2010), we explore inhibition among children with ADHD in 
Germany and Taiwan with the identical study design and task and further investigate the 
effect of MPH on response inhibition in children with ADHD at both sites. 
2 
To fulfill these purposes, in Chapter 2, we first give a brief overview on the topics 
relevant to ADHD, including diagnostic criteria, psychiatric comorbidity, and etiology. 
Chapter 3 focuses on response inhibition in ADHD by selectively reviewing behavioral, 
electrophysiological, and neuroimaging studies. Chapter 4 reviews the effects of medication 
and self-regulation strategies on response inhibition in ADHD. Chapter 5 introduces the 
potential impact of culture on children’s behaviors—one critical motive that guides the 
current research. Two studies are presented in Chapters 6 and 7, respectively. We first 
compare response inhibition measured by the Go/NoGo task (Paul et al., 2007) between 
children with ADHD and their healthy counterparts in Germany and Taiwan. Second, we 
explore the effect of medication on response inhibition in children with ADHD at both sites. 
In Chapter 8, general discussion and implications for future research regarding the findings 
from the current research are given. Finally, Chapter 9 concludes with implications for 
clinical practice. 
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2. Attention Deficit Hyperactivity Disorder 
Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder 
characterized by developmentally inappropriate behaviors such as inattention, hyperactivity, 
and impulsivity (American Psychiatric Association, 2000) with estimated prevalence rates 
of 5–10% among school-age children worldwide (Faraone, Sergeant, Gillberg, & 
Biederman, 2003), 5.3% in Germany (Huss, Hoelling, Kurth, & Schlack, 2008), and 7.5% 
in Taiwan (Gau, Chong, Chen, & Cheng, 2005). Children diagnosed with ADHD frequently 
display difficulty sustaining their attention or regulating their behaviors in everyday life 
(Nigg, 2001; Reid, Trout, & Schartz, 2005). They, for instance, cannot wait for their turn 
patiently when playing with others, tend to interrupt others when they are not supposed to, 
or seem not to listen when spoken to (American Psychiatric Association, 2000). Impacts of 
ADHD cardinal symptoms may persist into adolescence and adulthood (Barkley, 2004, 
2010; Barkley, DuPaul, & McMurray, 1990; Gau, Chiu, Shang, Cheng, & Soong, 2009; 
Miller, Ho, & Hinshaw, 2012). 
2.1 Diagnostic Criteria 
Two international classification systems are widely used by clinicians and 
psychiatrists for the diagnosis of ADHD: the Diagnostic and Statistical Manual of Mental 
Disorders (DSM; American Psychiatric Association, 2000, 2013) and the International 
Statistical Classification of Diseases and Related Health Problems (ICD; World Health 
Organization, 2008). The diagnostic criteria of ADHD in the text revision of the fourth 
version of the DSM (DSM-IV-TR; American Psychiatric Association, 2000) are based on 
two core symptom domains: inattention and hyperactivity/impulsivity (see Table 2.1). 
According to varying severity levels displayed on these two domains, three subtypes are 
outlined in ADHD: the predominantly inattentive type, the predominantly 
hyperactive/impulsive type, and the combined type.  
4 
Children are diagnosed with ADHD-predominantly inattentive type (ADHD-PI) 
when they meet criterion A in Table 2.1, while those meeting criterion B are diagnosed with 
ADHD-predominantly hyperactive/impulsive type (ADHD-HI), and those meeting both 
criteria A and B are diagnosed with ADHD-combined type (ADHD-C). Additional criteria 
also need to be met, including (a) the emergence of some inattentive or 
hyperactive/impulsive symptoms that cause impairments before the age of 7; (b) symptoms 
are required to cause impairments in at least two settings (e.g., both school and home); (c) 
evidence of clinical significant impairments is clear in social, academic, or occupational 
functioning, and (d) ADHD symptoms are not better explained by other mental disorders 
(e.g., pervasive developmental disorder, schizophrenia, and other psychotic disorders; 
American Psychiatric Association, 2000). 
In the tenth version of the ICD (ICD-10), the term hyperkinetic disorder (HD) is 
used to describe the signs of ADHD. Unlike the DSM-IV-TR, in which three subtypes are 
defined, no subtypes are distinguished in the ICD-10; only when individuals simultaneously 
meet criteria described in each core symptom (i.e., inattention and hyperactivity/impulsivity) 
are they diagnosed with HD. Other diagnostic criteria in the ICD-10 are similar to those in 
the DSM-IV-TR. Therefore, a diagnosis of ADHD based on the DSM-IV-TR is most 
consistent with a diagnosis of ICD-10 HD. 
Diagnostic criteria are associated with the variability of prevalence rates of 
ADHD/HD, which has been reported in several studies in different cultures and countries 
(e.g., Doepfner, Breuer, Wille, Erhart, & Ravens-Sieberer, 2008; Gau et al., 2005; Smalley 
et al., 2007). In general, the prevalence of ADHD based on the DSM-IV is higher than that 
of HD when using the ICD-10 criteria (Polanczyk, de Lima, Horta, Biederman, & Rohde, 
2007; Swanson et al., 1998). For example, Doepfner et al. (2008) reported in a national 
sample of children and adolescents aged 7-17 years that the prevalence rate of ADHD 
5 
according to DSM-IV criteria was 5.0%, and the rate of ICD-10 based HD was 1.0%. Other 
potential factors related to prevalence rates of ADHD/HD include source of information, 
patient’s age and gender, and impairments in other functioning (Gomez, Harvey, Quick, 
Scharer, & Harris, 1999; Polanczyk et al., 2007).  
6 
Table 2.1 
Diagnostic Criteria for Attention Deficit Hyperactivity Disorder 
Either A or B: 
A. Six (or more ) of the following symptoms of inattention have persisted for at least 6 months 
to a degree that is maladaptive and inconsistent with developmental level: 
Inattention  
(a) often fails to pay close attention to detail or makes careless mistakes in schoolwork, 
work, or other activities 
(b) often has difficulty sustaining attention in tasks or play activities 
(c) often does not seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to finish schoolwork, chores, or 
duties in the workplace (not due to oppositional behavior or failure to understand 
instructions) 
(e) often has difficulty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental 
effort (such as schoolwork or homework) 
(g) often loses things necessary for tasks or activities (e.g., toys, school assignments, pencils, 
books, or tools) 
(h) is often easily distracted by extraneous stimuli  
(i) is often forgetful in daily activities 
B. Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at 
least 6 months to a degree that is maladaptive and inconsistent with developmental level: 
Hyperactivity 
(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or in other situations in which remaining seated is 
expected 
(c) often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to subjective feelings or restlessness) 
(d) often has difficulty playing or engaging in leisure activities quietly 
(e) is often ―on the go‖ or often acts as if ―driven by a motor‖ 
(f) often talks excessively 
Impulsivity 
(g) often blurts out answers before questions have been completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e.g., butts into conversations or games) 
Source from DSM-IV-TR (American Psychiatric Association, 2000)  
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2.2 Psychiatric Comorbidity 
According to Pliszka (2009, p. 2), ―comorbidity can be simply defined as two or 
more diseases occurring in the same individual.‖ It has been noted that approximately half 
of children and adolescents with ADHD are diagnosed with comorbid disorders, including 
oppositional defiant disorder (ODD), conduct disorder (CD), mood disorder, anxiety 
disorders, learning disabilities, and Tic disorder (August, Realmuto, MacDonald, Nugent, & 
Crosby, 1996; Gau et al., 2010; Pliszka, 1998; Spencer, 2006). 
The rate of symptoms of psychiatric comorbid disorders may vary as a function of 
gender and/or subtype in childhood ADHD. However, findings from relevant studies are 
mixed. In a clinically-referred sample (Biederman et al., 2002), boys with ADHD were at 
significantly greater risk for comorbid externalizing problems (ODD/CD) than girls with 
this disorder, while the prevalence rates of ODD/CD were reported to be similar for boys 
and girls with ADHD in a community-based study, regardless of ADHD subtype (Levy, 
Hay, Bennett, & McStephen, 2005). In terms of comorbid internalizing problems, 
significant gender differences were observed for separation anxiety disorder (SAD) in the 
inattentive subtype and for generalized anxiety disorder (GAD) in the combined subtype; in 
both cases, higher rates of symptoms existed in girls than in boys (Levy et al., 2005). 
Furthermore, several factors are predictive for comorbidities in adolescents with 
persistent ADHD. For instance, more severe childhood ADHD symptoms predict ODD/CD 
at adolescence. Older age is a higher risk for mood disorders. Comorbidity of Tic disorder is 
associated with a longer duration of medication treatment (Gau et al., 2010). 
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2.3 Etiology 
ADHD is a highly multifactorial disorder, for which a number of causes have been 
proposed. The current view endorses the theory that genetic and neurobiological factors 
play a critical role in the cause of ADHD, while environmental and psychosocial influences 
may shape the expression of ADHD symptoms (Milberger, Biederman, Faraone, Guite, & 
Tsuang, 1997). A possible developmental pathway for ADHD (Mash & Wolfe, 2007) could 
be that genetic risk or prenatal alcohol exposure and pregnancy complications expose 
children to a risk of disturbances in dopamine transmission and abnormalities in the frontal 
lobe and basal ganglia. This then leads to a failure in adequately suppressing inappropriate 
responses, cognitive deficits, behavioral clinical symptoms, and impaired social functioning. 
Below is a selective overview on various etiologies for ADHD (see Figure 2.1). 
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Figure 2.1 A possible developmental pathway for ADHD. Figure adapted from Mash and 
Wolfe (2007, p. 138).  
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2.3.1 Genetic Factors 
Evidence from twin and adoption studies shows that ADHD is a familial and 
heritable disorder with a mean heritability estimate of 0.76 (Faraone et al., 2005). Several 
candidate genes involving the etiology of ADHD are implicated in molecular genetic 
studies (Faraone et al., 2005). Among these, genes encoding the dopamine transporter and 
receptors have been extensively studied, e.g., the dopamine receptor D4 and D5 (DRD4 and 
DRD5) and the dopamine transporter (DAT1/SLC6A3) genes (Faraone, Doyle, Mick, & 
Biederman, 2001). A meta-analysis (Faraone et al., 2001) of case-control and family-based 
studies examining the association between ADHD and the DRD4 gene demonstrated a 
small but statistically significant association between ADHD and the DRD4 7-repeat allele 
in each analysis. The combined estimates of the odds ratios (ORs) were 1.9 in control 
studies (95% confidence interval [CI] 1.4-2.2) and 1.4 in family studies (95% CI 1.1-1.6). A 
more recent analysis (Li, Sham, Owen, & He, 2006) also showed that the 7-repeat and 5-
repeat alleles of the DRD4 gene, as well as the 148-bp allele of the DRD5 gene, conferred 
increased risk for ADHD. Similarly, in a sample of Taiwanese children and adolescents 
with DSM-IV-diagnosed ADHD, Chen et al. (2003) found that the DAT1 gene increased 
susceptibility to ADHD (OR = 2.9). Moreover, variations of the DAT1 gene may primarily 
have an impact on the ADHD-predominantly inattentive subtype, not the other two subtypes 
(Shang, Gau, Liu, & Hwu, 2011). By far, evidence supports a critical dopamine component 
in the pathogenesis of ADHD. Other candidate genes have been of considerable interest to 
researchers, such as those related to the noradrenergic (NET/SLC6A2, ADRA2A, ADRA2C) 
and serotonergic (5-HTT/SLC6A4, HTR1B, HTR2A, TPH2) systems (for a review of this 
literature, see Banaschewski, Becker, Scherag, Franke, & Coghill, 2010; Faraone et al., 
2005). 
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2.3.2 Pregnancy and Birth Complications 
Biological adversity may contribute to the etiology of ADHD in addition to genetic 
influences. Other discussed biological factors include pregnancy, delivery, and infancy 
complications, and maternal smoking and alcohol-drinking during pregnancy. A positive 
association exists between childhood ADHD or associated impaired cognitive functioning 
and pregnancy, delivery, and infancy complications (Milberger et al., 1997). More 
specifically, using linear and logistic regression models, Milberger et al. (1997) revealed 
that risk factors such as maternal illness/infection, neonatal medical problems, maternal 
substance use/family problems, and maternal emotional problems/difficult infant were 
significantly associated with higher rates of ADHD, as well as with cognitive impairments 
in children. It was these specific complications reflecting chronic exposures that accounted 
for the association. Evidence from studies with a population-based sample (Thapar et al., 
2003) or a clinical sample (Milberger, Biederman, Faraone, Chen, & Jones, 1996) 
demonstrated that maternal smoking during pregnancy was positively associated with 
ADHD in children, and the association remained significant even after other potential 
confounds were taken into consideration. 
2.3.3 Brain Function 
Frontal lobe dysfunction has been an active focus of ADHD research over the past 
several decades, based on the observation that experimental animals or human patients with 
frontal lesions sometimes produce ADHD-like symptoms of hyperactivity or impulsivity 
alone or in combination (Fuster, 1993). 
Brain volume and structure. In a landmark neuroimaging study, Castellanos et al. 
(2002) compared brain volumes in the cerebrum, cerebellum, gray and white matter for the 
four major lobes (i.e., frontal, temporal, parietal, and occipital lobes), and caudate nucleus 
in approximately 150 children and adolescents with ADHD and 140 age- and sex- matched 
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healthy controls. Their primary findings were (a) brain volumes in all regions are 
significantly smaller in those with ADHD than in controls, regardless of sex; (b) group 
differences on the white matter for all lobes pronouncedly exist between unmedicated 
individuals with ADHD and controls, but not between medicated individuals with ADHD 
and controls, and (c) developmental trajectories of brain volume abnormalities (except 
caudate) that are independent of medical status remain stable and parallel for individuals 
with ADHD and healthy controls during childhood and adolescence. These findings suggest 
that influences of genes and/or early environment on brain development in ADHD are fixed, 
nonprogressive, and not related to stimulant treatment. 
With respect to brain structures, anatomical measures of frontostriatal circuitry 
(specifically, the prefrontal cortex, caudate nucleus, and globus pallidus) are abnormal in 
children with ADHD. Casey et al. (1997) demonstrated that these frontostriatal regions were 
correlated with performance on response inhibition tasks, and that significant correlations 
between task performance and anatomic measures of the prefrontal cortex and caudate 
nuclei existed predominantly in the right hemisphere, supporting the important role of the 
right frontostriatal structures in response inhibition. Other brain regions, such as the corpus 
callosum (Giedd et al., 1994), basal ganglia (Aylward et al., 1996), and anterior cingulate 
cortex (Bush et al., 1999) appear to be abnormal in individuals with ADHD. 
Neurotransmitters in the brain. Symptomatology of ADHD is associated with the 
dysregulation (i.e., too much or too little) of neurochemical systems in the brain, including 
norepinephrine, epinephrine, dopamine, and serotonin systems. A multistage model (Pliszka, 
McCracken, & Maas, 1996) is hypothesized to describe the underlying mechanisms in the 
pathophysiology of ADHD by focusing on the interaction of norepinephrine, epinephrine, 
and dopamine in modulation of attention and impulsive control. In this hypothesis, 
disruptions of neurotransmitter transmission at different stages are comprehensively 
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implicated. A higher level of norepinephrine or lower level of epinephrine, which often 
exists in children with ADHD, may be associated with inattention, as the imbalanced levels 
of neurotransmitters indirectly lead to a dysfunction in the posterior norepinephrine-
mediated attention system. The posterior attention system would then fail to efficiently 
separate from old stimuli, shift attention to the new ones, and read them out to the anterior 
dopamine-mediated system. Disruptions in the brain mechanism (i.e., the brainstem) or the 
dopamine system in the anterior lobe (e.g., the dorsolateral or the orbital medial frontal 
cortex) may result in individuals being unable to readily make responses, as dopamine plays 
a critical role in the execution of behaviors. This indicates that insufficient dopamine in the 
brain is correlated with impulse control.  
Moreover, the severity of childhood aggression and parental aggression is associated 
with low serotonergic function in children with comorbid ADHD and disruptive behavior 
disorders, indicating that low serotonin may put these children at greater risk for poor long-
term outcomes, adolescence, or adulthood aggression (Halperin et al., 1997). 
2.3.4 Psychopathology 
Deficits in executive functioning. According to Welsh and Pennington (1988), 
executive function is defined in a developmental neuropsychological way: 
….as the ability to maintain an appropriate problem-solving set for attainment of a 
future goal (Bianchi, 1992; Luria, 1966). This set can involve one or more of the 
following: (a) an intention to inhibit a response or to defer it to a later more 
appropriate time, (b) a strategic plan of action sequences, and (c) a mental 
representation of the task, including the relevant stimulus information encoded into 
memory and the desired future goal-state. (pp. 201–202) 
By definition, executive functions include set-shifting, inhibition, working memory, 
planning, contextual memory, and fluency (Pennington & Ozonoff, 1996). The concept of 
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executive function is characterized by ―context-specific action selection, especially in the 
face of strongly competing, but context-inappropriate, responses,‖ and ―maximal constraint 
satisfaction in action selection, which requires the integration of constraints from a variety 
of other domains, such as perception, memory, affect and motivation‖ (Pennington & 
Ozonoff, 1996, p. 55). 
Impaired executive functioning is reported in ADHD. Significantly, children with 
ADHD exhibit more inferior performance than do healthy controls on one or more tasks 
measuring the above-mentioned executive functions (Pennington & Ozonoff, 1996). 
Gawrilow, Gollwitzer, and Oettingen (2011), using a modified version of the Wisconsin 
Card Sorting Test (WCST), found that children with ADHD had higher perseverative errors, 
which were strongly associated with poorer set-shifting performance, than did children 
without ADHD. In a typical WCST, participants are instructed to match a series of cards to 
stimulus cards according to three categories (i.e., color, form, and number). The examiner 
only tells them if the card has been placed correctly or not, but they have to infer the sorting 
strategy from the feedback offered. Once 10 consecutive cards have been sorted correctly, 
the sorting principle is changed, unbeknownst to participants. Derived from the WCST is a 
measure of preservation, which is obtained by counting the number of times a participant 
adheres to a previously correct rule despite the negative feedback provided by the examiner 
(Heaton, Chelune, Talley, Kay, & Curtiss, 1993). The WCST preservation has proven to be 
the most widely-used and sensitive variable for investigating executive function deficits 
(Greve, Stickle, Love, Bianchini, & Stanford, 2005). 
Numerous studies with tasks tapping different executive functions (e.g., working 
memory, and inhibition) demonstrated that healthy controls displayed better performance 
than individuals with ADHD (e.g., Gawrilow & Gollwitzer, 2008; Gawrilow et al., 2011; 
Paul et al., 2007), which then led to the speculation that ADHD may have a mix of specific 
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and general deficits: a core executive function deficit (probably in inhibition), and another 
cognitive inefficiency. This conjecture, however, requires future studies to dissect executive 
function deficits and investigate their specificity in ADHD (Pennington & Ozonoff, 1996). 
Deficits in motivation. Children with ADHD prefer to choose an immediate small 
reward rather than a large one after an interval of time. Conducting two experiments in one 
study, Sonuga-Barke, Taylor, Sembi, and Smith (1992) demonstrated that children with 
ADHD and controls equally preferred the large reward during the no post delay (i.e., the 
next choice comes immediately after the reward is delivered) and post delay (i.e., the next 
choice appears a period of time after the reward is delivered) conditions in Experiment 1. 
In Experiment 2, neither group differed in percentage in choosing the large reward under the 
time constraint condition (i.e., children are instructed to gain more points during a certain 
period of time), but children with ADHD tended to choose the large reward less frequently 
than did healthy children under the trail constraint condition (i.e., children are instructed to 
gain more points in a limited number of choices). These results suggest that children with 
ADHD are delay-averse, resulting in their choosing rewards in a way that minimizes the 
overall delay. 
Furthermore, a more elaborate model of ADHD is proposed to describe a distinction 
between executive function and motivation control deficits in children with ADHD. 
According to the dual pathway model of behavior and cognition introduced by Sonuga-
Barke (2002), ADHD may not only pertain to a dysregulation of thought and action 
pathway (DTAP), but also to a motivational-style pathway (MSP). Both children with 
ADHD DTAP and ADHD MSP meet criteria for the ADHD-combined subtype even though 
they are characterized by distinct symptoms, development, etiology, and cognitive profiles, 
as described below. 
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The first pathway (ADHD DTAP) is manifested in a primary inhibitory dysfunction 
that is mediated by secondary cognitive and behavioral dysfunctions, which in turn lead to 
faulty task-engagement (e.g., deficits of set-shifting, working memory) and to symptomatic 
behaviors (e.g., inattentiveness, hyperactivity). ADHD DTAP seems further etiologically 
caused by neurobiological risk factors. Indeed, several studies and meta-analyses observed 
severe cognitive impairments, executive function deficits, and especially inhibition deficits 
in children with ADHD (Oosterlaan, Logan, & Sergeant, 1998; Oosterlaan & Sergeant, 
1996). The second pathway (ADHD MSP) is characterized by a dysregulation of reward 
mechanisms, leading to a higher preference for immediate rewards by children with ADHD. 
As associative learning plays an important role in the development of ADHD MSP, it is 
linked to environmental instead of neurobiological risk factors. ADHD MSP relates 
empirically to researchers observing delay-aversion and delay-of-gratification deficits in 
children with ADHD (Sonuga-Barke et al., 1992; Sonuga-Barke, Williams, Hall, & Saxton, 
1996). 
Deficits in behavioral inhibition. A number of prominent theories emphasizing 
disinhibition as the core deficit have emerged to elucidate the inappropriate behaviors 
observed in children and adolescents with ADHD (e.g., Barkley, 1997; Quay, 1997). Built 
on rigorous evidence from behavioral and neuropsychological studies, two biologically-
based systems are hypothesized in Quay’s (1997) theory: the behavior activation system 
(BAS) and behavior inhibition system (BIS). The BAS is sensitive to conditioned stimuli 
for reward, while the BIS responds to those for punishment and non-reward, leading 
individuals to passively avoid them and withhold responses. The BIS, however, is 
underactive in those with ADHD; thus they fail to inhibit their behaviors efficiently. 
Barkley (1997) proposes a neuropsychological model of executive functions by 
integrating the concepts of executive functions, inhibition, and self-regulation to account for 
17 
clinical symptoms of children with ADHD—specifically, those with combined subtype or 
predominantly hyperactive/impulsive subtype (American Psychiatric Association, 2000). 
According to this model, ADHD primarily arises from a deficit in behavioral inhibition, 
which refers to three abilities: (a) inhibition of prepotent responses to events, (b) ceasing of 
ongoing responses, and (c) the protection of responses during the delay from being 
interrupted by irrelevant events (interference control).  
Deficient behavioral inhibition leads to secondary impairments in four executive 
functions sub-served by the prefrontal lobe, including working memory, self-regulation of 
affect/motivation/arousal, internalization of speech, and reconstitution. To be executed 
efficiently, these four executive functions are dependent upon behavioral inhibition. Both 
primary and secondary deficits have direct or indirect impacts on the development of motor 
control. Abnormal executive functioning and motor control then develop to dysfunctional 
behaviors associated with ADHD (see Figure 2.2). 
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Figure 2.2 Barkley’s (1997) neuropsychological model of executive functions. Figure adapted from Barkley (1997). 
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2.3.5 Psychosocial Factors  
As mentioned earlier, psychosocial factors may not be the direct causes of ADHD. 
However, they have an important impact on the prognosis of this disorder and the 
development of comorbid disorders (Milberger et al., 1997). A variety of psychosocial risk 
factors may be influential in comorbid disorders and functional impairments in ADHD 
(Deault, 2010). For example, among children with ADHD, a lack of positive parenting, 
parental psychopathology, parenting stress and family conflict, and less social support are 
associated with comorbid externalizing disorders (e.g., oppositional defiant disorder and 
conduct disorder). Maternal anxiety and depression, and inconsistent parenting styles, are 
risk factors for the occurrence of comorbid internalizing disorders (e.g., anxiety and 
depression); better parenting skills are predictive of later positive outcomes regarding 
children’s academic achievement (Deault, 2010).  
Compared with parents of healthy children, those of children with hyperactivity 
exhibit poorer parenting and greater use of harsh and aggressive discipline methods toward 
their child—even after the confounding effects of child conduct problems and parental 
mental health are considered (Woodward, Taylor, & Dowdney, 1998). Early positive 
parenting, particularly maternal responsiveness, serves as a protective factor against the 
development course of conduct problems, aggression, and oppositional defiant behaviors, 
while maternal depression is predictive of the occurrence of conduct problems in young 
children with ADHD (Chronis et al., 2007; Seipp & Johnston, 2005). Maternal negativity is 
also a predictive factor of a child’s stealing (Anderson, Hinshaw, & Simmel, 1994). 
Parent-child interactions are associated with externalizing behaviors that frequently 
accompany children with ADHD. For example, boys who have a more negative interaction 
with their mothers are more likely to engage in externalizing behaviors. Similarly, with a 
Taiwanese sample of 375 medicated children with ADHD and 750 healthy controls, Gau 
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(2007) demonstrated that compared with families of controls, those of children with ADHD 
had more inappropriate parenting strategies, impaired family relationships, and increased 
parent–child conflicts. Mothers of children with ADHD reported that they had less parental 
care and were more overprotective toward their children. Findings from this study (Gau, 
2007) showed that children with ADHD and their families had difficulties interacting with 
each other, even though they were undergoing treatment. These findings, therefore, suggest 
that the parental approach should be incorporated in the medication treatment of ADHD. 
Taken together, although the current literature is supportive of the view that genetic 
and neurobiological factors play a critical role in the cause of ADHD, environmental and 
psychosocial factors are influential in the development of ADHD associated comorbid 
disorders and functioning impairments (Milberger et al., 1997). 
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3. Response Inhibition in Attention Deficit Hyperactivity Disorder 
According to Barkley’s (1997) model, behavioral inhibition refers to three 
interrelated processes: (a) inhibition of prepotent responses to events (motor response 
inhibition), (b) ceasing of ongoing responses, and (c) the protection of responses during the 
delay from being interrupted by irrelevant events (interference inhibition). For the issue of 
interest and the purpose of brevity, however, the current research is narrowly focused on 
one process, which is inhibiting prepotent responses to events. Therefore, in the sections 
that follow, the terms inhibition, response inhibition, and inhibitory control are used 
interchangeably to refer to this process. We mainly focus on studies of inhibition measured 
by the Go/NoGo or stop task—but do not focus on those studies using Stroop, Simon, or 
Flanker task, as these two groups of inhibition tasks are considered to tap into different 
cognitive constructs of inhibition (Hart et al., 2013), which are motor response inhibition 
(i.e., measured by the Go/NoGo or stop task) and interference inhibition (i.e., measured by 
Stroop, Simon, or Flanker task), respectively. 
3.1 Behavioral Correlates of Response Inhibition 
Impaired inhibitory control causes individuals with ADHD to perform more poorly 
than controls on tasks that require inhibition. Examples include the stop signal task (SST) 
(Pliszka, Borcherding, Spratley, Leon, & Irick, 1997; Pliszka, Liotti, & Woldorff, 2000; 
Rubia, Oosterlaan, Sergeant, Brandeis, & v. Leeuwen, 1998), Go/NoGo task (Paul-Jordanov 
et al., 2010), and the Continuous Performance Task (CPT), a version of the Go/NoGo task 
(Banaschewski et al., 2004; Doehnert, Brandeis, Imhof, Drechsler, & Steinhausen, 2010; 
Fallgatter et al., 2004; Seifert, Scheuerpflug, Zillessen, Fallgatter, & Warnke, 2003; Valko 
et al., 2009). Studies employing neuropsychological techniques support the literature by 
demonstrating abnormal activation in the prefrontal lobe and surrounding brain areas such 
as the cingulate cortex, where the inhibitory process is majorly governed (Bush, 2011; Bush 
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et al., 1999; Cubillo, Halari, Smith, Taylor, & Rubia, 2012; Pliszka et al., 2000; Rubia et al., 
1999). 
3.1.1 Stop Signal Task 
The SST is a reliable measure of response inhibition across the lifespan (Williams, 
Ponesse, Schachar, Logan, & Tannock, 1999). It has been extensively used with ADHD 
populations (e.g., MacLaren, Taukulis, & Best, 2007; Pliszka et al., 1997; Pliszka et al., 
2000). In a typical SST, there are a proportion of the Go stimuli (e.g., 25% of the total trials), 
followed by stop signals with randomized intervals (Logan, Cowan, & Davis, 1984; Pliszka 
et al., 1997). Participants are instructed to respond to Go stimuli by pressing corresponding 
buttons but to withhold their already-initiated responses when stop signals are presented. 
According to the Horse-Race Model (Logan et al., 1984), the probability of successful 
inhibitions is dependent on a race between the mean reaction time to the Go stimulus (MRT; 
the Go process) and the Stop Signal Reaction Time (SSRT; the Stop process), which is 
assumed to be an index reflecting an internal attempt to inhibit the response to stop signals.  
The SSRT is estimated by subtracting the delay between the Go stimulus and the 
stop signal (stop signal delay; SSD) from the MRT (i.e., SSRT = MRT – SSD). When the 
Go process finishes earlier than the Stop process (i.e., MRT < SSRT + SSD), the response is 
executed, resulting in a failed inhibition. In contrast, the response is successfully inhibited 
when the Stop process finishes before the Go process (i.e., MRT > SSRT + SSD). It is noted, 
however, that the skewedness of the reaction time (RT) distribution and gradual slowing 
response latencies may bias the SSRT estimates (Verbruggen, Chambers, & Logan, 2013). 
People who are more impulsive have longer SSRT than healthy controls (Logan, 
Schachar, & Tannock, 1997). Meta-analytic reviews (Alderson, Rapport, & Kofler, 2007; 
Lijffijt, Kenemans, Verbaten, & van Engeland, 2005) showed that children with ADHD had 
slower and more variable mean reaction times to Go stimuli than did healthy controls. 
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According to Alderson et al. (2007), effect size estimates were 0.45 for MRT and 0.72 for 
SDRT. Similarly, the SSRT was found to be significantly longer for the ADHD group than 
for the control group (mean effect size = 0.61; Willcutt, Doyle, Nigg, Faraone, & 
Pennington, 2005). These substantial findings point to abnormalities in response inhibition 
among children with ADHD.  
3.1.2 Go/NoGo Task 
Inhibition is also assessed with the Go/NoGo task (Broyd et al., 2005; Groom et al., 
2008; Groom, Scerif, et al., 2010; Johnstone, Barry, Markovska, Dimoska, & Clarke, 2009; 
J. L. Smith, Johnstone, & Barry, 2004). This is a task requiring a response to a type of 
stimulus (the Go stimulus; e.g., letters except X) and the withdrawal of a prepared but not 
yet initiated response to another type of stimulus (the NoGo stimulus; e.g., X). 
Compared to healthy controls, children with ADHD have been observed to display 
slower and more variable mean RTs (Epstein et al., 2011; Uebel et al., 2010) and exhibit 
more omission (i.e., people do not respond to Go stimuli to which they are required to 
respond) and commission errors (i.e., false alarm: an error occurring when people respond 
to NoGo stimuli to which they are not supposed to respond) (Broyd et al., 2005; Paul-
Jordanov et al., 2010). Several factors may modulate the behavioral performance of children 
with ADHD (e.g., mean RT, RT variability, and commission errors) on the Go/NoGo task 
(Epstein et al., 2011; Uebel et al., 2010). For example, children with ADHD tend to respond 
more quickly and accurately and less variably when rewarded immediately (Uebel et al., 
2010). A meta-analytic study (Metin, Roeyers, Wiersema, van der Meere, & Sonuga-Barke, 
2012) showed that the rate at which stimuli were presented (i.e., event rate [ER]) had an 
impact on mean RT (MRT) and errors of commission (EOC). Shorter MRTs and more 
EOCs with increasing ERs were observed both in the ADHD and control groups. However, 
the difference between the variables with slow ER and fast ER in the ADHD group was 
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disproportionate to that of healthy controls, resulting in significant group by event rate 
interactions (MRT: effect size [ES] between 0.22 and 0.26, p between .004 and .003; EOC: 
ES between -0.17 and -0.18, p between .006 and .001). No significance on the effect of ER 
on RT variability was observed in this meta-analysis (p for ES group x event rate between 0.03 
and 0.11). 
3.1.3 Mechanisms Underlying the Go/NoGo and Stop Signal Tasks 
Although the Go/NoGo task and SST are used interchangeably in measuring 
inhibition in ADHD, behavioral and neurological substrates for the two tasks may be 
distinct. According to Schachar et al. (2007), two forms of response inhibition are 
distinguished: action restraint and action cancellation. Action restraint is used to describe 
that inhibition of a pre-planned motor response occurs before the response has been initiated, 
while action cancellation describes that inhibition occurs while the motor response is 
executed. Action restraint and action cancellation refer to the inhibition measured with the 
Go/NoGo task and SST, respectively.  
The amount of time required for the inhibition of a motor response also differs 
between the two tasks. In the Go/NoGo task, the time in processing the NoGo stimulus 
includes response selection and response inhibition; in the stop task, participants withdraw 
their responses as quickly as they can upon the occurrence of the stop stimulus. They do so 
without selecting responses, as the stop stimulus occurs after the go process is already 
initiated (Rubia et al., 2001). Several brain regions are commonly activated in both tasks. 
However, the regions tend to be activated bilaterally for the Go/NoGo task and are more 
right-hemisphere-dominant for the stop task (Rubia et al., 2001). Moreover, with respect to 
the pharmacology of inhibition, serotonin plays a critical role in action restraint during the 
Go/NoGo task, while action cancellation for the stop task is related to noradrenaline (Eagle, 
Bari, & Robbins, 2008). 
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3.2 Electrophysiological Correlates of Response Inhibition 
Over the past decade, considerable studies have been conducted to obtain 
electrophysiological data when participants with or without ADHD are performing 
inhibition-related tasks (especially with the visual/auditory stop tasks) to enhance the 
understanding on the pathophysiology of ADHD and the neural mechanisms underlying 
inhibitory control in ADHD (Albrecht, Banaschewski, Brandeis, Heinrich, & Rothenberger, 
2005; Dimoska, Johnstone, Barry, & Clarke, 2003; Johnstone, Barry, & Clarke, 2013; 
Johnstone et al., 2007; Liotti, Pliszka, Higgins, Perez, & Semrud-Clikeman, 2010; Liotti et 
al., 2007; Overtoom et al., 2002; Senderecka, Grabowska, Szewczyk, Gerc, & Chmylak, 
2012; Shen, Tsai, & Duann, 2011). 
3.2.1 Stimulus-Related Event-Related Potentials 
In event-related potential (ERP) studies (e.g., Broyd et al., 2005; Pliszka et al., 2007), 
continuous electroencephalogram (EEG) data are collected when the participant is 
performing a cognitive task in which different types of stimuli/trials are repeatedly 
presented. Recorded EEG data are then averaged across many trials. This aims to cancel out 
the noise that may result from random brain activity, physiological signals such as 
electrooculography (EOG) and electrocardiography (EKG), as well as interference from the 
external environment (e.g., electronic noise). After that, a waveform is produced, 
representing brain activity in response to a type of stimulus in the task. Typically, two 
stimulus-locked ERP components—N2 and P3—are elicited when response inhibition tasks 
are administered. Both N2 and P3 are stable and heritable electrophysiological markers 
involved in the inhibitory process (Dimoska et al., 2003; Falkenstein, Hoormann, & 
Hohnsbein, 1999; Jodo & Kayama, 1992; McLoughlin et al., 2009; Overtoom et al., 2002; 
Overtoom, Verbaten, Kemner, Kenemans, van Engeland, et al., 1998; Pliszka et al., 2000; 
Seifert et al., 2003). 
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The N2 component. The N2, which is associated with conflict monitoring, is a 
negative-going shift with a peak at approximately 200 ms after stimulus onset. Functional 
responses of the N2 are mostly interpreted as the initiation of inhibitory processing. 
However, some studies adopting auditory stop task paradigms may complicate the 
inhibitory hypothesis by reporting the absence of the N2 effect in healthy controls 
(Falkenstein et al., 1999) or in the ADHD group (Fisher, Aharon-Peretz, & Pratt, 2011). 
One study (Dimoska et al., 2003) suggests that the N2 may be an indicator of the activation 
level of the inhibitory process. In accordance with the former view (i.e., the N2 represents 
the initiation of inhibition), amplitudes of the NoGo N2 are found to be larger over frontal-
central brain regions than those of the Go N2. This indicates that inhibitory processing is 
manipulated to withhold an ongoing but inappropriate response in NoGo trials (Broyd et al., 
2005; Falkenstein et al., 1999; Pliszka et al., 2007). With respect to the NoGo N2, 
Falkenstein et al. (1999) found in a Go/NoGo task that, relative to healthy controls, children 
with ADHD displayed a significant correlation between reduced N2 amplitudes for NoGo 
stimuli and higher commission errors, indicating a weakness in successfully inhibiting 
responses to NoGo stimuli in ADHD. Moreover, in the SST, Pliszka et al. (2007) 
demonstrated that children with ADHD exhibited a strongly diminished NoGo N2 in the 
right frontal lobe, a brain region found to be impaired in the inhibitory process (Rubia et al., 
1999; Rubia, Smith, Brammer, Toone, & Taylor, 2005). This corresponds to the observation 
that inhibition is executed with a right-hemisphere dominance (Garavan, Ross, & Stein, 
1999). 
The P3 component. Following the N2, the P3 deflects positively, peaking at around 
300 ms after stimulus onset. This component is closely linked to selective attention and 
allocation of efforts (Picton, 1992). In Go/NoGo studies, greater amplitudes and longer 
latencies are observed in NoGo trials than in Go trials, indicating greater demand on 
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resources in processing NoGo trials (Fallgatter & Strik, 1999; Overtoom, Verbaten, Kemner, 
Kenemans, van Engeland, et al., 1998; Picton, 1992; Pliszka et al., 2007). The NoGo P3 is 
observed to be diminished in ADHD, which results in P3 amplitude differences between 
NoGo and Go trials being significantly smaller in children with ADHD relative to normally 
developing children (Paul-Jordanov et al., 2010) and reflects poor attention and impaired 
response control in the ADHD group.  
The NoGo P3 has higher frontal-central/anterior topographical distribution than does 
the Go P3 (Bokura, Yamaguchi, & Kobayashi, 2001; Fallgatter et al., 2004; Picton, 1992; 
Tekok-Kilic, Shucard, & Shucard, 2001). Distinct scalp distributions suggest that different 
neural cortical generators underlie the Go and NoGo P3 (Tekok-Kilic et al., 2001). The Go 
P3 is recorded maximally at parietal electrode sites (Fallgatter et al., 2004). The 
topographical distribution of the NoGo P3 is accounted for by dipoles located in the anterior 
cingulate cortex (ACC) (Paul et al., 2007), a central brain area consistently reported to be 
dysfunctional in the ADHD group from electrophysiological and neuroimaging studies 
(Bush et al., 1999; Fallgatter et al., 2004). 
Similarly, studies using other paradigm tasks found abnormal P3 response in ADHD. 
For instance, Strandburg et al. (1996) found reduced and delayed visual P3, and diminished 
late frontal negativity but normal neuronal activity related to the early stages of stimulus 
processing in children with ADHD. This suggests deficits in post-decisional processing. 
Jonkman et al. (1997) reported that children with ADHD were more likely than healthy 
controls to exhibit smaller P3 amplitudes toward non-target stimuli, both in auditory and 
visually selective attention tasks. They hypothesized that the activation of the P3 process 
was impaired in ADHD. Likewise, Overtoom et al. (1998) reported that significantly 
attenuated P3 amplitudes toward targets were observed in the ADHD group during a visual 
continuous performance task as compared to normal controls, while no group significance 
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regarding amplitudes of the inhibition-related negative waves existed. This indicates a 
deficit in attention but not in impulsivity (or inhibition).  
Prox, Dietrich, Zhang, Emrich, and Ohlmeier (2007) demonstrated that the P3 had a 
link with decreased activity in adults with ADHD. Together with other findings that early 
ERP components related to attention mechanisms were enhanced in ADHD, Prox et al. 
(2007) suggested that adults with ADHD might manage to achieve the same task 
performance as controls and compensate for their deficits by paying more attention than 
healthy adults. Using an oddball auditory task, Itagaki et al. (2011) found that the P3 was 
significantly decreased in amplitude, but not prolonged in latency, among ADHD adults 
relative to the control group. 
Associations between age and the N2 and P3. Differential response patterns of the 
N2 and P3 components on inhibition are modulated by age difference (Johnstone, Pleffer, 
Barry, Clarke, & Smith, 2005). For instance, using the auditory Go/NoGo task, Johnstone et 
al. (2005) found that in healthy subjects, the N2 and P3 increased in amplitude and 
decreased in latency across developmental ages of childhood, and in young and older adults. 
The effect of the NoGo N2 being larger than the Go N2 in amplitude—particularly over the 
frontal scalp—diminished with age, with the largest and most reduced effects observed in 
children and young adults, respectively. However, a minor reversed difference in older 
adults was found, in contrast to the previous finding that no significant age effect existed on 
the NoGo N2 with visual Go/NoGo tasks (e.g., Jonkman, Lansbergen, & Stauder, 2003). 
Other studies found that this effect was only restricted to the younger children in the ADHD 
group, while a Go > NoGo N2 effect was observed in older children with ADHD (e.g., 
Broyd et al., 2005).  
Taken together, these mixed findings may indicate that differential mechanisms in 
processing stimuli are adopted between age groups or between ADHD and control groups 
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(Broyd et al., 2005). For the P3, the NoGo P3 has a more anterior scalp distribution relative 
to the Go P3 across age in the control and ADHD groups (Broyd et al., 2005; Falkenstein et 
al., 1999). The NoGo P3 effect is more pronounced in the older age group than the younger 
age group, both in visual and auditory modality (Broyd et al., 2005; Johnstone et al., 2005; 
Jonkman et al., 2003). 
Some researchers attribute their results to a general deficit in attention rather than 
inhibition; they found that a significant diminished P3 exists in the adult ADHD group in 
comparison to healthy controls (Itagaki et al., 2011; Prox et al., 2007; Rodriguez & Baylis, 
2007; Sawaki & Katayama, 2006). However, a number of studies with different tasks and 
methodologies tested on adults with ADHD have substantially demonstrated that the child 
and adolescent ADHD patterns characterizing deficient inhibitory control persist into 
adulthood, implying that impaired inhibition may be still critical to clinical ADHD 
symptomatology (Aron, Dowson, Sahakian, & Robbins, 2003; Boonstra, Kooij, Oosterlaan, 
Sergeant, & Buitelaar, 2005, 2010; Epstein, Johnson, Varia, & Conners, 2001; Fallgatter et 
al., 2005; Lijffijt et al., 2005; MacLaren et al., 2007; Murphy, 2002; Nigg, Butler, Huang-
Pollock, & Henderson, 2002; Ossmann & Mulligan, 2003; Schneider et al., 2007; 
Wodushek & Neumann, 2003).  
For example, regarding the behavioral performance on the stop task, a meta-analysis 
of 29 studies (Lijffijt et al., 2005) revealed that the indices of deficient inhibitory control, 
such as the prolongation of SSRT, existed significantly in the ADHD group relative to 
controls robustly across the groups’ lifespan. On measures of inattention, such as longer 
RTs and variable standard deviation RT (i.e., SDRT), a pronounced difference between 
groups was observed among the child population (see also Alderson et al., 2007), but not 
seen in the adult population. Within the adult ADHD group, SSRT can vary according to the 
level of ADHD symptoms. Individuals with high levels of ADHD symptoms, who are 
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supposed to experience more difficulties inhibiting their responses, are reported to have 
longer SSRT than those with low levels of ADHD symptoms (Wodushek & Neumann, 
2003). 
From the perspective of electrophysiology, one study (Valko et al., 2009) showed 
that the inhibition-related component (i.e., NoGo P3) was attenuated in children and adults 
with ADHD relative to their healthy counterparts; impacts yielded by ADHD symptoms on 
electrophysiological performance were evident despite developmental effects. Another 
study (MacLaren et al., 2007) applying the stop task also demonstrated a diminished N2/P3 
complex in adults with ADHD in the absence of a significant difference on the behavioral 
measures. 
Inconsistent with the notion of deficient inhibitory control in ADHD, one study 
(Wiersema, van der Meere, Antrop, & Roeyers, 2006) adopted the Go/NoGo paradigm and 
found no pronounced group differences in terms of the N2 response. As noted by Wiersema 
et al. (2006), however, this study may be limited by its relatively small size. Meanwhile, 
some potential confounding variables that may lead to inconsistent results/conclusions need 
to be taken into serious consideration—for example, the level of the task demand and the 
composition of the participant population. 
Associations between cognitive functioning and the P3. In addition to age effect, 
cognitive functioning is associated with the P3 response (e.g., Dichter, van der Stelt, Boch, 
& Belger, 2006; O'Donnell, Friedman, Swearer, & Drachman, 1992; Pelosi et al., 1992; van 
der Stelt, Frye, Lieberman, & Belger, 2004). However, evidence from the ADHD group is 
more limited compared to that from the nonclinical and schizophrenia samples. 
Investigations of correlations between neuropsychological functioning (e.g., intelligence 
and working memory) and the P3 response have been reported with component latencies 
and amplitudes among clinical patients (Dichter et al., 2006; Egan et al., 1994; van der Stelt 
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et al., 2004) or healthy individuals (O'Donnell et al., 1992; Pelosi et al., 1992). Several lines 
of evidence have indicated that neuropsychological functioning is associated positively with 
P3 amplitude, but negatively with P3 latency (e.g., Dichter et al., 2006; Jaušovec & 
Jaušovec, 2000; Polich, Howard, & Starr, 1983). For example, P3 latency was reported to 
be inversely correlated with digit-span performance in normal individuals. As digit-span 
performance was considered as a measure of working memory, relatively short P3 latencies 
were hypothesized to reflect decreased memory function (Polich et al., 1983). 
Walhovd and Fjell (2002) found that the P3 latency-digit span correlation was 
weaker for backward spans than for forward spans and total spans, while the P3 amplitude-
digit span correlation was not dependent on the type of digit span. Additionally, with 
auditory and visual oddball task, Jaušovec and Jaušovec (2000) demonstrated that highly 
intelligent people were more likely than those with less intelligence to display reduced P3 
latencies and increased P3 amplitudes. Given that the P3 amplitude reflects cognitive 
resources allocated to process the stimuli (Kok, 2001) and the P3 latency indexes the time 
of stimulus evaluation (Kutas, McCarthy, & Donchin, 1977), Jaušovec and Jaušovec (2000) 
suggested a simultaneous activation of more specific neural networks in highly intelligent 
individuals during the cognitive tasks. Similarly, O'Donnell et al. (1992) reported a 
significant negative relationship of P3 latency with intelligence (-0.44) and with 
concentration (-0.33). 
After controlling for measures of executive functioning, Dichter et al. (2006) found 
a positive relationship between the estimated intelligence score and P3 amplitude in the 
control group, but a negative relationship in schizophrenic patients. They demonstrated that 
shorter P3 latencies were associated with higher estimated intelligence in healthy controls, 
but not in the schizophrenia group. These findings suggest that the association between P3 
response and intelligence may differ between diagnostic groups, indicating that measures of 
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executive functioning should be included in investigations aimed at exploring the P3-
intelligence relationship. 
3.2.2 Failed Response Inhibition-Related Event-Related Potentials 
Two error-related components have received increasing attention and have been 
reported in several inhibition-related studies using the flanker task (Herrmann et al., 2010), 
and the Go/NoGo task (Groom, Cahill, et al., 2010; O'Connell et al., 2009; Wiersema, van 
der Meere, & Roeyers, 2009) or the SST (Liotti, Pliszka, Perez, Kothmann, & Woldorff, 
2005; Senderecka et al., 2012; Shen et al., 2011). After the onset of incorrect button presses, 
the error-related negativity (ERN), a negative-going component with a frontal-central scalp 
distribution, is evoked at approximately 100 ms, while the error positivity (Pe) peaks at 300 
ms over the central-parietal scalp (Senderecka et al., 2012). Both components, which appear 
to be generated in the ACC, represent different aspects associated with error processing 
(Garavan, Ross, Murphy, Roche, & Stein, 2002). More specifically, the ERN may be 
elicited unconsciously and reflect the detection of an error resulting from a conflict between 
the intended and actual responses; the Pe occurs only when the participant is aware of an 
erroneous response (Shen et al., 2011; Wiersema et al., 2009). 
Deficits in error processing have been reported in ADHD children (Senderecka et al., 
2012; Shen et al., 2011), adolescents (Groom, Cahill, et al., 2010), and adults (O'Connell et 
al., 2009; Wiersema et al., 2009), which may partially be associated with poor performance 
observed during inhibition tasks. Inconsistent findings on the ERN amplitude are evident in 
a number of studies. Studies using the SST either in visual (Liotti et al., 2005) or auditory 
modality (Senderecka et al., 2012) demonstrated that the ERN was markedly diminished in 
the ADHD group relative to healthy children. Some studies found that larger ERNs were 
observed in the ADHD group (Burgio-Murphy et al., 2007); other studies with the 
Go/NoGo task found no significant group differences on the ERN in child (Wiersema, van 
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der Meere, & Roeyers, 2005) and adult populations (Wiersema et al., 2009). By contrast, 
the Pe is found to be consistently smaller in the ADHD group than in controls regardless of 
developmental age (Groom, Cahill, et al., 2010; O'Connell et al., 2009; Senderecka et al., 
2012; Wiersema et al., 2005; Zhang, Wang, Cai, & Yan, 2009). Therefore, these findings 
imply that—rather than error detection—abnormal neural activity in the late stage of error 
processing (i.e., conscious evaluation of an error), which is indexed by reduced Pe, appears 
to serve as a lifelong trait marker in ADHD (Wiersema et al., 2009; Zhang et al., 2009). 
3.3 Evidence from Neuroimaging Studies on Response Inhibition 
The right inferior prefrontal cortex serves as the crucial brain region for response 
inhibition. The mesial frontal cortex, including the anterior cingulate cortex and bilateral 
inferior parietal lobes, is responsible for error detection or error monitoring (Rodrigo et al., 
2014; Rubia, Smith, Brammer, & Taylor, 2003). Abnormal brain activity in these regions 
has been reported in individuals with ADHD across their lifespans (Cubillo et al., 2010; A. 
Smith, Taylor, Brammer, Toone, & Rubia, 2006), and certain brain dysfunction (i.e., the 
right inferior prefrontal cortex) is reportedly disorder-specific to ADHD (Rubia et al., 2010). 
However, findings from neuroimaging or event-related potential studies are mixed. 
In a functional magnetic resonance imaging (fMRI) study with the SST, Pliszka et al. (2006) 
found that children with ADHD were more likely than healthy controls to show decreased 
activation in the anterior cingulate cortex and left ventrolateral prefrontal cortex for 
unsuccessful inhibitions, but increased activation in the right inferior performance cortex for 
successful inhibitions. The finding of enhanced right inferior prefrontal cortex activation 
was in line with earlier reports of increased activation of the right ventrolateral prefrontal 
cortex in adolescents with childhood ADHD during the Go/NoGo task (Schulz et al., 2004). 
However, they were inconsistent with a previous study (Rubia et al., 2005) that found 
reduced activation in the right inferior prefrontal cortex in medication-naïve adolescents 
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with ADHD performing the stop task. These discrepant results could be explained by 
different experimental designs or techniques in the studies (Pliszka et al., 2006). 
A recent meta-analysis of fMRI studies (Hart et al., 2013) showed that individuals 
with ADHD, compared to controls, exhibited significantly reduced activation in the right 
inferior frontal cortex (IFG) and insula, the right supplemental motor area (SMA) and ACC, 
the right thalamus, left caudate, and the right occipital lobe. Moreover, studies found that 
frontal-striatal and parietal dysfunction during motor inhibition, which were observed in 
children (Rubia et al., 2010), adolescents (A. Smith et al., 2006), and adults (Cubillo et al., 
2010) with ADHD, were unrelated to long-term stimulant medication exposure (Pliszka et 
al., 2006; A. Smith et al., 2006). These dysfunction similarities between age groups may 
therefore suggest a continuation of frontostriatal inhibitory network deficits from childhood 
to young adulthood in ADHD (Cubillo et al., 2010). 
Furthermore, Cubillo et al. (2010) observed reduced functional interconnectivity 
between critical brain areas involving inhibition (i.e., between the right inferior prefrontal 
cortex and other dysfunction regions such as left inferior prefrontal cortex, striatum, parietal 
lobe, and anterior and posterior cingulate), indicating that the dysfunctions in ADHD may 
affect not only isolated brain regions but also the inter-regional connectivity between these 
affected regions. This finding and evidence from other studies (e.g., Shang, Wu, Gau, & 
Tseng, 2013; Wolf et al., 2009) extend the functional deficit findings on motor inhibitory 
control in ADHD to the neural network level. 
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3.4 Brief Summary 
Taken together, evidence from behavioral, event-related potential, or neuroimaging 
studies supports that individuals with ADHD are impaired in inhibitory control to some 
degree. Although altered response patterns of the stimulus-related N2 and P3, and error-
related ERN/Pe during the inhibitory processing (e.g., amplitudes, latencies, and 
topographical distributions) have been consistently demonstrated in ADHD, findings on the 
electrophysiological performances of adults with ADHD are relatively mixed due to limited 
literature in comparison with those on children and adolescents with ADHD. As a result, 
future studies with different paradigms are needed to confirm the previous findings and to 
further characterize the electrophysiological patterns and facilitate clear investigations in 
light of inhibition and pathophysiology in ADHD across the human lifespan. 
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4. Effects of Medication and Self-Regulation Strategies on Response Inhibition 
4.1 Medication 
Stimulant treatment. Methylphenidate (MPH), a central nervous system (CNS) 
stimulant, has been widely discussed in studies on the treatment of ADHD (e.g., Broyd et al., 
2005; Goldman, Genel, Bezman, & Slanetz, 1998; Paul-Jordanov et al., 2010). Two 
formulations of MPH are the most commonly prescribed medications in clinical practice: 
immediate-release-MPH (IR-MPH) for thrice-daily administration, and long-acting 
osmotic-release oral system-MPH (OROS-MPH) for once-daily administration. OROS-
MPH is found to have better treatment effects relative to IR-MPH (Gau, Shen, Soong, & 
Gau, 2006), as individuals with ADHD have higher adherence rates to OROS-MPH than 
IR-MPH (Tzang et al., 2012). In the U.S., the rate of individuals aged 18 years and below 
using stimulants rose from 0.6% in 1987 to 4.8% in 2002 (Zuvekas, Vitiello, & Norquist, 
2006). Approximately 48.6 million daily doses of MPH in Germany were prescribed in 
1990; this number increased to 1036 million daily doses in 2000 (Schubert, Selke, Osswald-
Huang, Schroeder, & Nink, 2002). In Taiwan, MPH is the first-line medication to treat 
ADHD. Its immediate-release formulation (i.e., IR-MPH) has been used for decades, and as 
of October 2003 (Gau et al., 2006), osmotic-release MPH is accepted as an alternative for 
ADHD treatment. Even though the rates of using stimulant treatment differ in different 
populations, these trends show that an increasing number of children are treated with 
psychotropic drugs. 
Effects are exerted by MPH on two catecholamine systems: norepinephrine and 
dopamine systems. Both are critical for the operation of executive functioning but are found 
to be dysfunctional in ADHD studies on humans (Pliszka et al., 1996) and animals (Grund, 
Lehmann, Bock, Rothenberger, & Teuchert-Noodt, 2006). MPH restores the levels of 
norepinephrine and dopamine in synaptic clefts in individuals with ADHD by binding to 
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corresponding transporters on the presynaptic neuron membrane, and then preventing the 
reuptake of neurotransmitters in brain areas related to attention or motor control (Jensen, 
2009; Scahill, Carroll, & Burke, 2004). 
A body of empirical studies and meta-analyses has documented that MPH has short-
term or long-term efficacy in improving most clinical symptoms in children with ADHD 
(e.g., Abikoff et al., 2004; Schachter, Pham, King, Langford, & Moher, 2001; Van der Oord, 
Prins, Oosterlaan, & Emmelkamp, 2008). This documentation is based not only on 
subjective ratings by teachers, parents, and psychiatrists (Abikoff et al., 2004; Van der Oord 
et al., 2008) but also on objective measurements combined with the infrared motion system 
(Heiser et al., 2004). Similarly, MPH is effective in ameliorating impaired response 
inhibition measured by inhibition tasks, which is reflected on electrophysiological or 
behavioral measures and has been demonstrated in child (Tannock, Schachar, Carr, 
Chajczyk, & Logan, 1989; Tannock, Schachar, Carr, & Logan, 1989), adolescent (Barkley, 
2004), and adult (Murphy, 2002) populations. Aron et al. (2003) showed that SSRT was 
significantly faster in adults between 18 and 41 years of age when off medication than on 
medication. However, no significant differences were observed between the two medication 
conditions in terms of reaction times to Go stimuli and choice errors. Overall, individuals 
with ADHD exhibited more error rates than did their healthy counterparts prior to 
medication; after the treatment with MPH, the error rates were significantly reduced in the 
ADHD group (Aron et al., 2003). 
Regarding evidence from electrophysiological studies, the NoGo N2 and P3 
amplitudes are smaller in the unmedicated ADHD group relative to the control group. But 
after the treatment of MPH, amplitudes of the N2 and P3 do not differ between groups 
(Broyd et al., 2005; Paul-Jordanov et al., 2010). Using a stop signal task, Pliszka et al. 
(2007) demonstrated the differential effects of MPH on the N2 and P3 by comparing 
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amplitudes of both components in children and adolescents with ADHD when off and on 
medication. Independent of gender and age, increased NoGo N2 amplitudes were observed 
after the treatment of MPH over the right inferior frontal lobe on successful inhibition trials, 
while the enhancements of the ACC-originated NoGo P3 were exclusively limited to failed 
inhibition trials. This indicates that different brain regions might be responsible for different 
cognitive functioning (i.e., the right frontal lobe for inhibition, while ACC for attention re-
allocation after an error occurs) during the inhibitory process (Pliszka et al., 2007). 
Neuroimaging studies showed that MPH enhances the activation of the right inferior frontal 
cortex (IFG)/insula, brain regions which are critical for inhibitory control but dysfunctional 
in ADHD (Rubia et al., 2014). MPH ameliorates response inhibition by exerting its effect 
on attention networks associated with response control requirements (Pauls et al., 2012).  
Nonstimulant treatment. Another alternative medication treatment used for ADHD 
is nonstimulant medication such as atomoxetine. Atomoxetine is a selective norepinephrine 
reuptake inhibitor. The efficacy of atomoxetine in the management of ADHD has been 
reported in clinical studies from different countries, e.g., the U.S. (Kelsey et al., 2004), 
Russia (Martenyi et al., 2010), Germany (Wehmeier et al., 2012), and Taiwan (Gau et al., 
2007). Atomoxetine is effective in reducing not only the core symptoms of ADHD (Gau et 
al., 2007; Martenyi et al., 2010; Wehmeier et al., 2012) but also oppositional symptoms 
(Gau et al., 2007; Michelson et al., 2001). For instance, with a large sample of 106 patients, 
Gau et al. (2007) demonstrated that atomoxetine is an effective, well-tolerated, and safe 
treatment for children and adolescents with ADHD in Taiwan. In addition, atomoxetine 
improves inhibitory control in healthy adults (Chamberlain et al., 2009) and adults with 
ADHD (Chamberlain et al., 2007). 
Atomoxetine exerts its beneficial effects on inhibition by modulating right inferior 
frontal functioning (Chamberlain et al., 2009). In general, the efficacy of atomoxetine is 
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comparable with that of MPH in the treatment of ADHD (Hanwella, Senanayake, & de 
Silva, 2011; Hazell et al., 2011). However, some meta-analytic studies point out that 
OROS-MPH could be more effective than atomoxetine and may be considered as the first-
line treatment in children and adolescents with ADHD (Hanwella et al., 2011). 
4.2 Self-Regulation Strategies 
Recently, a growing number of papers reveal that the self-regulation strategy of 
implementation intentions has an effective impact regarding the support of inhibition tasks 
in the ADHD group (Gawrilow & Gollwitzer, 2008; Gawrilow et al., 2011; Paul-Jordanov 
et al., 2010). An implementation intention (Gollwitzer, 1993, 1999), which is a specific 
form of a plan, emphasizes an anticipated critical situation (i.e., the if-component) and a 
goal-directed response (i.e., the then-component). It is important to recognize that 
implementation intentions differ from goal intentions. Goal intentions merely specify an 
anticipated outcome and have the format of ―I intend to achieve Z.‖ When people form an 
implementation intention, a mental link is made between the two components (―If situation 
X arises, then I will initiate goal-directed response Y‖). ―Implementation intentions are 
subordinate to goal intentions because, whereas a goal intention specifies what one will do, 
an implementation intention spells out the when, where, and how of what one will do‖ 
(Sheeran, Webb, & Gollwitzer, 2006, p. 123). 
As forming an if-then plan (see Figure 4.1) implies the selection of a future situation, 
the mental representation of this situation becomes highly activated, and therefore more 
easily accessible. Additionally, this critical cue automatically triggers the intended (and pre-
planned) response and/or behavior: it is enacted immediately, efficiently, and without 
conscious intent (e.g., Bayer, Achtziger, Gollwitzer, & Moskowitz, 2009). Both 
mechanisms—the heightened accessibility of the cue and the automatic activation of the 
intended behavior—produce a perceptual and behavioral readiness that accounts for if-then 
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plan effects on goal attainment (e.g., Webb & Sheeran, 2008). In this way, implementation 
intentions help people initiate their actions more automatically, thereby enhancing the self-
regulation of goal striving and the attainment of self-set or assigned task goals effectively. 
If-then plans have been proven to have benefits above mere goal intentions: A meta-analysis 
by Gollwitzer and Sheeran (2006) revealed an effect size of d = 0.65; a medium-to-large 
effect size (Cohen, 1992) representing the additional facilitation size of this effect is 
remarkable, because goal intentions commonly have a facilitating effect on behavior 
enactment in and of themselves (Webb & Sheeran, 2006). 
A study conducted by Gawrilow and Gollwitzer (2008) showed that children with 
ADHD benefited from forming if-then plans for a modified Go/NoGo task. This task 
required participants to classify stimuli that were presented on a computer screen by 
pressing a pre-specified key on the computer keyboard, and then inhibit this classification in 
response to a NoGo signal. Children with ADHD were randomly assigned to one of two 
groups. Children in the goal intention group formed a goal to inhibit a classification 
response for marked stimuli. Children in the implementation intention group, in addition to 
forming this goal intention, formed an if-then plan. In their first study, Gawrilow and 
Gollwitzer (2008) compared the performance of children with and without ADHD. Children 
without ADHD performed at a high level, no matter whether they had formed a goal 
intention or an implementation intention. Children with ADHD, however, reached the high 
performance level only when they had complemented the goal intention with an if-then plan; 
children with ADHD in the goal intention-only condition showed a significantly lower 
performance level. 
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Figure 4.1 Components, mechanisms, and outcomes of implementation intention formation. 
Figure adapted from Sheeran et al. (2006). 
 
Paul et al. (2007) collected electrophysiological data when children with and without 
ADHD were performing the Go/NoGo task under two different task instruction conditions: 
the baseline condition without a self-regulation strategy, and the planning condition with a 
self-regulation strategy. The children with ADHD went through both conditions, which was 
the only difference from the previous study (Gawrilow & Gollwitzer, 2008), in which 
children with ADHD were randomly assigned to either condition. The Go/NoGo task 
consisted of 300 stimuli (50% colored drawings of transportation vehicles and 50% colored 
drawings of animals). Children were asked to respond to animals and vehicles by pressing 
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one of two colored buttons, respectively. The correspondence of stimulus type and 
response-button was reversed after the first half of the experiment to prevent the task from 
becoming too easy. In 33% of the trials, a stop sign—a white outspread hand on a circular 
purple background—was presented before the stimulus. This was actually the only 
difference to the task used by Gawrilow and Gollwitzer (2008), in which a tone was used as 
the stop signal. The stop sign indicated that no response was to be given on the following 
trial.  
The trials following stop signs were treated as NoGo trials; all other trials were Go 
trials. In the baseline condition, children received a neutral instruction containing 
information regarding how to perform the task (e.g., pressing different buttons 
corresponding to animals or vehicles and not pressing any buttons whenever the hand was 
shown). In the planning condition, children were given an instruction furnished with an if-
then plan (i.e., if I see a hand, then I will not press a button). This study (Paul et al., 2007) 
showed that more inhibition errors were found in children with ADHD than controls in the 
baseline condition. No group difference was significantly revealed in the planning condition. 
Response errors to Go stimuli did not differ between ADHD and control children in the 
baseline and planning conditions. Slower reaction times were found to be significant in the 
ADHD group relative to the control group across both conditions. Moreover, children with 
ADHD exhibited greater NoGo P3 and NoGo-Go (NoGo minus Go) P3 with the assistance 
of the self-regulation strategy of if-then plans in comparison to their electrophysiological 
performance in the baseline condition. This indicates that a better response control was 
achieved, supported by the high correlation between the successful inhibition and the 
NoGo-Go P3 amplitude difference (Paul et al., 2007). As the P3 is an ERP component 
related to selective attention (Picton, 1992) and the NoGo P3 is usually reduced in children 
with ADHD (e.g., Fallgatter et al., 2004), the self-regulation strategy of if-then plans is 
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apparently effective for enhancing inhibitory control in children with ADHD (Paul-
Jordanov et al., 2010). 
More recently, the application of if-then plans has been extended to various settings 
such as school settings, with promising findings. Guderjahn, Gold, Stadler, and Gawrilow 
(2013) found that children with ADHD from grades five to ten in a secondary school 
exhibited improved self-regulatory competencies with the assistance of if-then plans (i.e., 
the use of goal intention furnished with if-then plans) compared with their performances in 
the baseline (i.e., the use of goal intention) in everyday school life. 
4.3 Brief Summary 
To sum up, MPH is effective for improving ADHD symptoms. Careful 
pharmacological treatment has been demonstrated to be superior to behavioral treatment in 
reducing ADHD core symptoms. However, combined (i.e., behavioral intervention and 
stimulant medication) and behavioral treatments relative to medication alone are beneficial 
in supporting family functioning (The MTA Cooperative Group, 1999a). Research on 
behavioral intervention, reviewed in this section, provides clinicians another perspective 
concerning the management of ADHD by demonstrating that forming if-then plans is 
effective for the behavioral and electrophysiological correlates of response inhibition 
measured by the Go/NoGo task. Thus, the self-regulation strategy could be an effective 
behavioral strategy without adverse effects in the support of inhibition in ADHD (Paul-
Jordanov et al., 2010). 
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5. The Current Research 
One motive that guides the current research is that developmental patterns are 
strongly influenced by cultural setting (Cheie, Veraksa, Zinchenko, Gorovaya, & Visu-Petra, 
2015; Wanless et al., 2011). Culture, in which individuals are deeply embedded, is an 
influential factor in shaping how parents educate their children (Keller, 2007) and mediating 
relationships of parenting with children’s developmental functioning (Lansford, et al., 2005). 
For example, across six countries, Lansford, et al. (2005) demonstrated that mothers’ use of 
physical punishment was associated with children’s behavioral problems, but the link was 
stronger in countries where physical punishment is not viewed as a common rearing strategy. 
Investigating associations between child’s inhibitory control, harsh parental discipline and 
externalizing problems in preschoolers in the U.S., China, and Japan, Olson et al. (2011) 
found that a child’s externalization problems were pronouncedly associated with harsh 
maternal discipline and low levels of inhibitory control in all three countries. Moreover, 
harsh maternal discipline was negatively correlated with a child’s inhibitory control, but this 
was observed only in China and Japan, not in the U.S. (Olson et al., 2011). 
Parenting practices may vary across cultures. Generally, in Chinese culture, socially-
restrained behaviors are endorsed, while disruptive behaviors are prohibited (Chen, Cen, Li, 
& He, 2005). Chinese parents have less tolerance of aggressive and disruptive behaviors 
than Western parents, e.g., Americans, (Entwisle, Alexander, & Olson, 2007), because 
children’s behavioral regulation is highly valued in Chinese society. Also, strong behavioral 
regulation could contribute to success in children’s early academic achievement (Wanless et 
al., 2011). Similarly, in Taiwanese culture, children are educated to regulate themselves and 
act in a proper manner, especially when elder family members are around (Hsieh, 2004). 
Prior research on the socialization of self-regulation found that more aggressive and 
noncompliant behaviors occurred in German preschoolers than Japanese preschoolers 
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(Trommsdorff and Kornadt, 2003). Additionally, Asian parents tend to prepare in advance 
for what their children need before their children tell them, whereas Western parents (i.e., 
Germans and Americans) prefer to allow their children more independence to cope with a 
variety of situations (Trommsdorff, Cole, & Heikamp, 2012). Furthermore, parental rearing 
practices may influence the brain’s organization of cognition, resulting in different 
behavioral performance on neuropsychological measures (Meyer, 2005). Hence, the 
previous finding of deficient inhibition in ADHD may be constrained by the generalizability 
to other ethnic groups, because the task to date has been only used in one cultural context 
(i.e., Germany) (Gawrilow & Gollwitzer, 2008; Paul-Jordanov et al., 2010; Paul et al., 
2007). 
Thus, the current research aims at assessing behavioral inhibition with the identical 
assessment and procedure in different cultural settings and further exploring the effect of 
MPH on inhibition in children with ADHD. To fulfill the aims, we incorporate data and 
results from prior research (the German sample) with permission (Paul-Jordanov et al., 2010) 
and add new findings from a sample (the Taiwanese sample) in the present research. Two 
studies are conducted in the sections that follow. Study 1 compares response inhibition 
between children with ADHD and healthy controls in Germany and Taiwan. Study 2 further 
investigates the effect of MPH on response inhibition in children with ADHD at both sites. 
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6. Study 1: Response Inhibition among Children with and without ADHD in 
Germany and Taiwan 
6.1 Overview of the Study 
In Study 1, incorporating the data from the previous study (Paul-Jordanov et al., 
2010), we compared the behavioral performance of children with and without ADHD as 
measured by the Go/NoGo task (Paul-Jordanov et al., 2010) in Germany and Taiwan. We 
hypothesized that children with ADHD at both sites were more likely than their healthy 
counterparts to exhibit poor performance on NoGo trials (i.e., they had more difficulties 
inhibiting their responses on NoGo trials). Additionally, based on the previous research 
(Broyd et al., 2005; Fallgatter et al., 2004), we predicted that for both sites, children with 
ADHD would respond to Go trials less accurately and more slowly than would non-ADHD 
children. 
6.2 Method 
6.2.1 Participants 
Germany. The sample consisted of 11 (all boys) children who were diagnosed with 
ADHD combined type (American Psychiatric Association, 2000) as their primary disorder, 
and 16 (including three girls) age-matched healthy children (mean age ± SD: ADHD: 12.4 ± 
0.4 years vs. Control: 12.5 ± 0.3 years, respectively). Children participated after giving 
written informed consent. All of the children with ADHD were taking prescribed 
medication, while none of the controls had any clinically relevant diagnoses or were taking 
any medication, according to their parents. The study was approved by the research ethics 
committee of the University of Konstanz, and is compliant with the World Medical 
Association Declaration of Helsinki. Children with ADHD were recruited through a 
collaborating child psychiatric outpatient center in Konstanz. Control children were 
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contacted through the participant record system of the University of Konstanz (source from 
Paul-Jordanov et al., 2010). 
Taiwan. The sample included 19 children with ADHD (including two girls) and 16 
healthy controls (including one girl), aged 8 to 12 (mean age ± SD: ADHD: 9.72 ± 1.14 
years vs. Control: 10.12 ± 0.92 years). All participants were required to have a full IQ score 
≥ 80. Likewise, children with ADHD were recruited from the National Taiwan University 
Hospital and verified by the head child psychiatrist to have ADHD combined type 
(American Psychiatric Association, 2000) based on the DSM-IV criteria, while controls 
were recruited from the local schools and had no clinically relevant diagnoses. The study 
was approved by the research ethics committee of the National Taiwan University Hospital, 
and is compliant with the World Medical Association Declaration of Helsinki. 
6.2.2 Procedure 
All children at both sites underwent one Go/NoGo task session. If children with 
ADHD were taking medication for ADHD during participation, they were required to be 
free of medication 48 hours before the test, with a physician’s approval. Mothers were 
asked to complete the CBCL/SNAP-IV while their children were performing the task. 
6.2.3 Maternal Interview - Chinese Version of the Kiddie Epidemiologic version of 
the Schedule for Affective Disorders and Schizophrenia (K–SADS-E) 
In Taiwan, mothers of children with or without ADHD were interviewed after their 
child was referred by psychiatrists or recruited from local schools, in order to confirm the 
child’s diagnoses. Previous studies have proved the CK–SADS-E to be a reliable and valid 
instrument to assess child psychiatric disorders in Taiwan. The CK-SADS-E has been 
widely used in a variety of studies on the mental illnesses of children and adolescents in 
Taiwan (Gau et al., 2009; Gau et al., 2005; Gau et al., 2010). 
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6.2.4 Child Behavior Checklist – Parent Form (CBCL; Achenbach, 1991) 
This scale is designed to assess competencies and behavioral/emotional problems in 
children ages 4 to 18. The problem items are scored into eight specific scales: aggression, 
anxiety/depression, inattention, delinquency, social problems, somatic complaints, thought 
problems, and withdrawal. The Chinese (Yang, Chen, & Soong, 2001; Yang, Soong, 
Chiang, & Chen, 2000) and German (Arbeitsgruppe Deutsche Child Behavior Checklist, 
1998) versions of the CBCL were used for the Taiwanese and German samples, respectively. 
The German and Chinese versions of the CBCL have been widely used in previous ADHD 
studies (e.g., Gau, Lin, Shang, Liu, & Chiu, 2010; Paul-Jordanov et al., 2010). 
6.2.5 Swanson, Nolan, and Pelham IV Scale (SNAP-IV) – Parent Form 
In Taiwan, the SNAP-IV was used in addition to the CBCL to assess ADHD and 
ODD symptoms of children. The SNAP-IV consists of 26 items for ADHD and ODD 
symptoms of the DSM-IV (Swanson et al., 2001). Items included in the scale address the 
criteria of ADHD, which are inattention (items 1 – 9) and hyperactivity/impulsivity (items 
10 – 18), and the criteria of ODD (items 19 – 26). The SNAP-IV is based on a 4-point rating 
scale (Not at all = 0, Just a little = 1, Quite a bit = 2, and Very much = 3) to describe the 
degree to which the behavior is abnormally frequent and severe as compared to normal 
childhood behavior. The Chinese version of the SNAP-IV (Liu, et al., 2006) was reported to 
have satisfactory test-retest reliability, internal consistency, concurrent validity, and 
discriminant validity of the subscales (i.e., inattention, hyperactivity/impulsivity, and ODD) 
and is used often in ADHD research (e.g., Gau et al., 2007) 
6.2.6 Neuropsychological Task 
Germany. The classification task combined with a Go/NoGo task consisted of 300 
stimuli (50% colored drawings of transportation vehicles and 50% colored drawings of 
animals) (see Figure 6.1). The stimuli lasted 1000 ms and were presented with an ISI of 
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1500 ms. A fixation cross was shown 500 ms before each stimulus, in the middle of the 
screen. Children were asked to respond to animals and vehicles by pressing one of two 
colored buttons, respectively. The correspondence of stimulus type and response-button was 
reversed after the first half of the experiment, to prevent the task from becoming too easy. A 
practice session of 30 trials was introduced in each half of the experiment to ensure that 
children understood the task. In 33% of the trials, a stop sign—a white spread-out hand on a 
circular purple background—was presented 150 ms before the stimulus. The stop sign 
indicated that no response was to be given on the following trial. The trials using stop signs 
were treated as NoGo trials; all other trials were Go trials (source from Paul-Jordanov et al., 
2010). 
Taiwan. The Chinese version of the Go/NoGo task was adapted from the task used 
in Germany. However, the Chinese version is slightly different from the German version of 
the Go/NoGo task in which a total number of 360 stimuli was included in the Go/NoGo task, 
and the practice session in each half of the task consisted of 16 trials. The rest of the task 
was the same as the German version of the Go/NoGo task. 
6.2.7 Data Analysis 
Behaviorally, three dependent variables—the rate of correct responses on Go trials, 
the rate of correctly inhibiting responses on NoGo trials, and reaction times in correct Go 
trials—were analyzed. Student’s independent t-tests and Mann-Whitney U-tests were 
computed for between-group comparisons when data were normally distributed and not 
normally distributed, respectively. Accordingly, for the German sample, Mann-Whitney U-
tests were used for response data of Go and NoGo trials and Student’s independent t-tests 
were computed for reaction times in Go trials (source from Paul-Jordanov et al., 2010). For 
the Taiwanese sample, the Mann-Whitney U-test was used only for response data of NoGo 
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trials; Student’s independent t-tests were computed for correct response rates and reaction 
times on Go trials. The significance level of all statistical analyses was 5%. 
 
 
 
 
 
 
 
Figure 6.1 Examples of Go and NoGo trials. Source from Gawrilow and Gollwitzer (2008). 
 
6.3 Results 
Germany. The ADHD group scored higher than the norm overall on internalization 
and externalization of the CBCL (all Ts > 63), while the control group scored in the normal 
range on the three scales (all Ts < 56.91). Children with ADHD had lower correct rates than 
non-ADHD children on Go and NoGo trials (Z = -2.94, p = .002 and Z = -2.13, p = .03, 
respectively, see Table 6.1). Additionally, as shown in Table 6.2, children with ADHD 
exhibited pronouncedly slower reaction times than did controls (p = .004) (source from 
Paul-Jordanov et al., 2010). 
Taiwan. A shown in Table 6.3, children with ADHD scored significantly higher 
than non-ADHD controls on most of the scales of the CBCL (Aggressive behavior: ADHD: 
66.0 ± 13.58 vs. Control: 46.20 ± 8.37, p < .001; Anxious/Depressed: ADHD: 60.86 ± 14.86 
vs. Control: 48.59 ± 7.80, p = .007 ; Attention problems: ADHD: 63.11 ± 9.10 vs. Control: 
41.14 ± 4.28, p < .001; Delinquent behavior: ADHD: 57.74 ± 10.31 vs. Control: 45.65 ± 
3.29, p < .001; Social problems: ADHD: 62.72 ± 12.56 vs. Control: 46.49 ± 6.06, p < .001; 
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Thought problems: ADHD: 70.27 ± 20.92 vs. Control: 45.38 ± 5.87, p < .001; Withdrawn: 
ADHD: 54.10 ± 10.86 vs. Control: 44.79 ± 5.52, p = .009; Internalizing problems: ADHD: 
57.31 ± 12.65 vs. Control: 46.0 ± 7.08, p = .005; Externalizing problems: ADHD: 64.67 ± 
12.92 vs. Control: 45.84 ± 6.21, p < .001), except on the scale of somatic complaints 
(ADHD: 50.98 ± 11.12 vs. Control: 45.12 ± 5.68, p = .072).  
Similarly, group differences were pronouncedly found on ADHD (Inattention: 
ADHD: 56.0 ± 7.74 vs. Control: 45.15 ± 5.80, p < .001; Hyperactivity/Impulsivity: ADHD: 
53.90 ± 4.70 vs. Control: 45.04 ± 3.72, p < .001) and ODD symptoms (ADHD: 53.53 ± 
11.41 vs. Control: 42.20 ± 5.18, p = .001) of the SNAP-IV. 
In terms of the behavioral performance on the Go/NoGo task (i.e., rates of correct 
Go trials, reaction times on Go trials, and correct inhibition rates on NoGo trials), Shapiro-
Wilk’s tests (p > .05) (Shapiro & Wilk, 1965; Razali & Wah, 2011) and visual inspections 
of corresponding histograms, normal Q-Q plots, and box plots were used for the normality 
tests of sample distributions. The results showed that the rates of correct Go trials were 
approximately normally distributed for both ADHD and control groups. There was a 
skewness of 0.39 (Standard Error SE = 0.52) and a kurtosis of -0.51 (SE = 1.01) for the 
ADHD group and a skewness of -0.90 (SE = 0.56) and a kurtosis of -0.09 (SE = 1.09) for 
healthy controls. Similarly, the reaction times on Go trials were approximately normally 
distributed for both groups, with a skewness of -0.73 (SE = 0.52) and a kurtosis of 0.31 (SE 
= 1.01) for children with ADHD and a skewness of -0.07 (SE = 0.56) and a kurtosis of -0.02 
(SE = 1.09) for controls. The tests of normality for correct NoGo trials (i.e., responses are 
successfully inhibited) were at significance levels for both groups (ADHD: p < .001 vs. 
Control: p < .05). Additionally, Levene’s tests were used to verify the equality of variances 
on the rates of correct Go trials and reaction times on Go trials in the samples (homogeneity 
of variance) (p > .05) (Martin & Bridgmon, 2012). A non-parametric Levene’s test verified 
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the equality of variances in the samples (homogeneity of variance) (p > .05) (Nordstokke & 
Zumbo, 2010; Nordstokke, Zumbo, Cairns, & Saklofske, 2011). 
Compared with healthy children, children with ADHD responded to Go trials less 
accurately (t(33) = -5.45, p < .001) and more slowly (t(33) = 3.55, p = .001). No significant 
group differences were found with respect to the rates of successfully inhibiting responses 
on NoGo trials (Z = -0.83, p = .406, see Table 6.4). Additionally, analyses of covariance 
were used to assess whether the group differences still significantly exist in terms of the 
rates of correct Go trials and reaction times on Go trials after controlling for the ages of the 
children. Results showed that the covariate, child’s age, was not significantly related to the 
rates of correct Go trials, F(1, 32) = 2.90, p = .098. A main effect of Group on the rates of 
correct Go trials was still pronounced after controlling for age, F(1, 32) = 26.70, p < .001. 
However, the covariate, child’s age, was significantly related to the reaction times on Go 
trials, F(1, 32) = 12.65, p = .001, indicating that older children responded to Go trials more 
quickly than younger children, F(1, 32) = 12.65, p = .001. A significant main effect of 
Group on the reaction times on Go trials remained after controlling for age, F(1, 32) = 11.28, 
p = .002. 
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Table 6.1 
Behavioral Results for the ADHD and Control Groups in Germany 
Variable 
ADHD 
(N = 11) 
Controls 
(N = 16) 
Statistic p value 
Correct Go trials (%)     
 Median 77.1 85.4 Z = -2.94 .002 
 Minimum 55.8 74.2   
 Maximum 86.3 90.8   
Correct NoGo trials (%)     
 Median 88.3 95.4 Z = -2.13 .030 
 Minimum 45.8 80.8   
 Maximum 99.2 99.2   
Note. RT = reaction time. Table adapted with permission from Paul-Jordanov et al. (2010). 
 
Table 6.2 
Reaction Time Results (Go Trials) for the ADHD and Control Groups in Germany 
Variable 
ADHD 
(N = 11) 
Controls 
(N = 16) 
Mean RT (ms) 656.26* 542.96 
95% CI  
Lower boundary 
598.68 497.43 
95% CI  
Upper boundary 
713.84 588.48 
Note. RT = reaction time; CI = confidence interval. *Significant differences between  
children with ADHD and control children. Table adapted with permission from Paul-
Jordanov et al. (2010). 
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Table 6.3 
Sample Characteristics in Taiwan 
Variable 
ADHD 
Mean ± SD 
Controls 
Mean ± SD 
Statistics 
t value p value 
 (N = 19) (N = 16)   
Age (years) 9.72 ± 1.14 10.12 ± 0.92 -1.14 .264 
Male, n (%) 17 (89.5) 15 (93.8)   
Right handedness, n (%) 19 (100.0) 15 (93.8)   
CBCL – mother report (T score) (N = 17) (N = 13)   
 Aggressive behavior 66.0 ± 13.58 46.20 ± 8.37 4.92 < .001 
 Anxious/Depressed 60.86 ± 14.86 48.59 ± 7.80 2.92 .007 
 Attention problems 63.11 ± 9.10 41.14 ± 4.28 8.77 < .001 
 Delinquent behavior 57.74 ± 10.31 45.65 ± 3.29 4.54 < .001 
 Social problems 62.72 ± 12.56 46.49 ± 6.06 4.66 < .001 
 Somatic complaints 50.98 ± 11.12 45.12 ± 5.68 1.88 .072 
 Thought problems 70.27 ± 20.92 45.38 ± 5.87 4.67 < .001 
 Withdrawn 54.10 ± 10.86 44.79 ± 5.52 2.82 .009 
 Internalizing problems 57.31 ± 12.65 46.0 ± 7.08 3.11 .005 
 Externalizing problems 64.67 ± 12.92 45.84 ± 6.21 5.27 < .001 
SNAP-IV – mother report 
(T score) 
(N = 17) (N = 14)   
 Total score 55.63 ± 6.43 44.19 ± 4.71 5.53 < .001 
 Inattention 56.0 ± 7.74 45.15 ± 5.80 4.33 < .001 
 Hyperactivity/ Impulsivity 53.90 ± 4.70 45.04 ± 3.72 5.73 < .001 
 Oppositional defiant disorder 53.53 ± 11.41 42.20 ± 5.18 3.66 .001 
Note. SD = standard deviation; CBCL = Child Behavior Checklist.  
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Table 6.4 
Behavioral Results for the ADHD and Control Groups in Taiwan 
Variable 
ADHD 
(N = 19) 
Mean ± SD 
Controls 
(N = 16) 
Mean ± SD 
Statistic p value 
Go RT (ms) 697.09 ± 55.88 626.62 ± 61.58 t = 3.55 .001 
Correct Go trials (%) 61.72 ± 12.22 81.79 ± 8.96 t = -5.45 <.001 
Correct NoGo trials 
(% median) 
96.67 97.49 Z = -0.83 .406 
Note. SD = standard deviation; RT = reaction time. 
 
6.4 Discussion 
In accordance with the hypotheses, the findings in the current study showed that 
lower correct rates and longer reaction times on Go trials existed among children with 
ADHD relative to local non-ADHD children both in Germany and Taiwan. However, the 
finding of decreased correct rates on NoGo trials in the ADHD group in Germany was not 
observed in the Taiwanese sample; the ADHD and control groups in Taiwan displayed 
equal rates on correct NoGo trials. We speculate that one possible reason for the 
discrepancy could be that the task was less demanding or challenging for participants in 
Taiwan; thus they could perform well on the task where inhibition is required. However, 
this should be interpreted with caution, as the sample sizes at both sites are small (also see 
Chapter 8 for more detailed discussion). 
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7. Study 2: Behavioral Investigation of the Effect of Methylphenidate among 
Children with ADHD in Germany and Taiwan 
7.1 Overview of the Study 
The primary aim of Study 2 was to investigate the effect of medication on 
behavioral performance as measured by the Go/NoGo task among children with ADHD, 
with the repeated testing of both ADHD and control groups in Germany and Taiwan. 
Therefore, we invited the children with and without ADHD in Study 1 to take part in Study 
2. For the ADHD group, only those who were on medication or planning to take medication 
were recruited in Study 2. The Go/NoGo task was administered to children with ADHD at 
both sites when they were off and on medication. 
7.2 Method 
7.2.1 Participants 
Germany. As in Study 1, the sample consisted of 11 (all boys) children who were 
diagnosed with ADHD combined type (American Psychiatric Association, 2000) as their 
primary disorder and 16 (including three girls) age-matched non-ADHD children (mean age 
± SD: ADHD: 12.4 ± 0.4 years vs. Control: 12.5 ± 0.3 years). Children participated after 
giving written informed consent. All of the children with ADHD were taking prescribed 
medication, while none of the controls had any clinically relevant diagnoses or were taking 
any medication, according to their parents. The study was approved by the research ethics 
committee of the University of Konstanz and is compliant with the World Medical 
Association Declaration of Helsinki. Children with ADHD were recruited through a 
collaborating child psychiatric outpatient center in Konstanz. Control children were 
contacted through the participant record system of the University of Konstanz (source from 
Paul-Jordanov et al., 2010 and see Paul-Jordanov et al., 2010 for more details).  
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Taiwan. The sample included 10 children with ADHD (including two girls) and 14 
healthy controls (one girl), aged 8 to 12 (mean age ± SD: ADHD: 9.86 ± 1.05 years, Control: 
10.25 ± 0.88 years). All participants are required to have a full IQ score ≥ 80. Likewise, 
children with ADHD were recruited from the National Taiwan University Hospital and 
verified by the head child psychiatrist to have ADHD combined type (American Psychiatric 
Association, 2000) based on the DSM-IV criteria, while controls were recruited from the 
local schools and had no clinically relevant diagnoses. The study was approved by the 
research ethics committee of the National Taiwan University Hospital and is compliant with 
the World Medical Association Declaration of Helsinki. 
7.2.2 Procedure 
All participants at both sites underwent two Go/NoGo task sessions, approximately 
one month apart (Germany: ADHD: 42.5 ± 6.9 days, Control: 34.6 ± 5.7 days; Taiwan: 
ADHD: 36.6 ± 10.17 days, Control: 33.79 ± 7.32 days). Children on medication for ADHD 
at both sites were required to be free of medication 48 hours before the first test session with 
physician approval (Study 1), but they took their usual dosage of medication before the 
second test session. After completing the second session, participants were compensated 
with 20 Euro (Germany) (source from Paul-Jordanov et al., 2010) or approximately 13 Euro 
(Taiwan). 
7.2.3 Neuropsychological Task 
Germany. The classification task combined with a Go/NoGo task consisted of 300 
stimuli (50% colored drawings of transportation vehicles and 50% colored drawings of 
animals) that were presented on a computer screen approximately 60 cm from the children’s 
eyes. The stimuli lasted 1000 ms and were presented with an ISI of 1500 ms. A fixation 
cross was shown 500 ms before each stimulus, in the middle of the screen. Children were 
asked to respond to animals and vehicles by pressing one of two colored buttons, 
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respectively. The correspondence of stimulus type and response-button was reversed after 
the first half of the experiment, to prevent the task from becoming too easy. A practice 
session of 30 trials was introduced in each half of the experiment to ensure that children 
understood the task. In 33% of the trials, a stop sign—a white spread-out hand on a circular 
purple background—was presented 150 ms before the stimulus. The stop sign indicated that 
no response was to be given on the following trial. The trials using stop signs were treated 
as NoGo trials; all other trials were Go trials (source from Paul-Jordanov et al., 2010). 
Taiwan. The Chinese version of the Go/NoGo task was based on the task used in 
Germany. However, the Chinese version was slightly different from the German version of 
the Go/NoGo task in that a total number of 360 stimuli was included, and the practice 
session in each half of the task consisted of 16 trials. The rest of the task was the same as 
the German version of the Go/NoGo task. 
7.2.4 Data Analysis 
Behaviorally, the rate of correct responses on Go trials, the rate of correctly 
inhibiting responses on NoGo trials, and reaction times in correct Go trials were analyzed. 
At both sites, when data were not normally distributed, Mann-Whitney U-tests for between-
group comparisons or Wilcoxon tests for within-group comparisons were computed. When 
data were normally distributed, Student’s independent t-tests or paired t-tests were used for 
independent (i.e., comparisons between ADHD and control groups) or paired (i.e., 
comparisons between first/without medication and second/with medication sessions) 
samples, respectively (also refer to Paul-Jordanov et al., 2010 for data analysis in detail on 
the German sample). The significance level of all statistical analyses was 5%. 
7.3 Results 
Germany. Children with ADHD had lower correct rates than non-ADHD children 
on Go and NoGo trials during the first (unmedicated) session (Z = -2.94, p = .002 and Z = -
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2.13, p = .03, respectively, see Table 7.1). During the second (medicated) session, 
significant group differences existed only on Go trials (Z = -2.1, p = .03) but not on NoGo 
trials (Z = -0.7, p = .5). No within-group differences between the first and second sessions 
were revealed for either group (ADHD: Z = 0.3, p = .76 and Z = 1.2, p = .23 for Go and 
NoGo trials, respectively; Control: Z = 0.9, p = .36 and Z = 0.1, p = .91 for Go and NoGo 
trials, respectively) (source from Paul-Jordanov et al., 2010).  
Additionally, as shown in Table 7.2, a significant interaction was revealed for 
reaction time on correct Go trials (F (1, 24) = 7.24, p = .013). Children with ADHD 
exhibited pronouncedly longer reaction times than did controls in the first (unmedicated) 
session (p = .004), while the groups did not differ in the second (medicated) session (p 
= .13). That is, the children with ADHD responded to Go trials significantly quicker in the 
medicated session as compared to the unmedicated session (p = .001). No differences 
between the sessions were observed for the control group (p = .80) (source from Paul-
Jordanov et al., 2010). 
Taiwan. As shown in Table 7.3, children with ADHD scored significantly higher 
than controls on most of the scales of the CBCL (Aggressive behavior: ADHD: 65.27 ± 
16.50 vs. Control: 46.73 ± 8.50, p = .01; Anxious/Depressed: ADHD: 65.89 ± 18.12 vs. 
Control: 48.94 ± 8.04, p < .05; Attention problems: ADHD: 64.61 ± 10.55 vs. Control: 
41.60 ± 4.14, p < .001; Delinquent behavior: ADHD: 57.78 ± 12.19 vs. Control: 45.95 ± 
3.25, p < .05; Social problems: ADHD: 62.33 ± 12.91 vs. Control: 46.96 ± 6.08, p < .01; 
Thought problems: ADHD: 72.32 ± 22.01 vs. Control: 45.68 ± 6.03, p < .01; Internalizing 
problems: ADHD: 59.83 ± 16.07 vs. Control: 46.27 ± 7.32, p < .05; Externalizing problems: 
ADHD: 64.09 ± 15.42 vs. Control: 46.34 ± 6.21, p < .01), except on the scales of somatic 
complaints (ADHD: 51.30 ± 12.39 vs. Control: 45.34 ± 5.87, p = .158) and withdrawn 
(ADHD: 53.72 ± 14.42 vs. Control: 44.90 ± 5.75, p = .068).  
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Similarly, group differences were pronouncedly found on ADHD (Inattention: 
ADHD: 57.07 ± 8.86 vs. Control: 45.90 ± 5.28, p = .001; Hyperactivity/Impulsivity: ADHD: 
55.46 ± 5.18 vs. Control: 45.28 ± 3.76, p < .001) and ODD symptoms (ADHD: 54.29 ± 
14.90 vs. Control: 42.65 ± 5.10, p = .05) of the SNAP-IV. 
With regard to the behavioral performance (i.e., the rates of correct Go and NoGo 
trials and reaction times on Go trials) on the Go/NoGo task, we used Student’s independent 
t-tests or Mann-Whitney U-tests to assess whether ADHD and non-ADHD children who 
participated in Study 2 are different from ADHD and non-ADHD children who did not 
participate in Study 2, respectively, before we compared children with ADHD and controls 
in Study 2. Results showed that significant differences were not observed in the rates of 
correct Go trials (ADHD: t(17) = -0.34, ns vs. Control: t(14) = 0.02, ns), reaction times of 
Go trials (ADHD: t(17) = 0.18, ns vs. Control: t(14) = -0.66, ns), and rates of correct NoGo 
trials (ADHD: Z = -0.45, ns vs. Control: Z = -0.88, ns). 
Consistent with those findings in the German sample, unmedicated children with 
ADHD in Taiwan were more likely than healthy controls to display lower rates of correct 
Go responses (ADHD: M = 62.66%, SD = 14.18% vs. Control: M = 81.77%, SD = 8.83%, 
t(22) = 2.35, p < .05) and longer reaction times (ADHD: M = 694.79 ms, SD = 68.25 ms vs. 
Control: M = 630.53 ms, SD = 64.30 ms, t(22) = -4.08, p = .001) (see Figures 7.1 and 7.2), 
while the two groups differed pronouncedly on the rate of correct Go trials (ADHD: M = 
68.63%, SD = 12.73% vs. Control: M = 82.11%, SD = 11.25%, t(22) = -2.74, p < .05) but 
not on reaction times to Go trials (ADHD: M = 671.26 ms, SD = 90.87 ms vs. Control: M = 
624.84 ms, SD = 72.33 ms, t(22) = 1.39, p = .177) during the second (medicated) session 
(see Figures 7.1 and 7.2). For the ADHD group, a significant difference between sessions 
was observed on the rate of correct Go trials (t(9) = -3.18, p < .05) with a large effect size (d 
= 1.01) but not on reaction times to Go trials (t(9) = 1.63, p = .138) with a medium effect 
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size (d = 0.51) (see Table 7.4). For the control group, no differences between the two 
sessions were pronouncedly observed on the rate of correct Go trials (t(13) = -0.41, p = .893) 
and reaction times to Go trials (t(13) = 0.39, p = .706) (see Table 7.4). 
Similar to the results in Study 1, significant differences on the rate of correct NoGo 
trials between the ADHD and control groups were not observed in either of the two sessions 
(1
st
 session: Z = -0.824, p = .410; 2
nd
 session: Z = -0.479, p = .632). No within-group 
differences between the sessions existed for the children with ADHD (Z = -1.020, p = .308) 
and non-ADHD controls (Z = -1.735, p = .083) (see Table 7.5). 
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Table 7.1 
Behavioral Results (% Correct Go Responses; % Correct Inhibitions after NoGo Sign) for 
the ADHD and Control Groups in Germany 
Group Trial Session 
Median 
% correct 
Minimum 
% correct 
Maximum 
% correct 
ADHD Go Unmedicated/1 77.1* 55.8 86.3 
  Medicated/2 80.4* 53.3 87.1 
 NoGo Unmedicated/1 88.3* 45.8 99.2 
  Medicated/2 91.7 n.s. 42.5 99.2 
Control Go 1 85.4 74.2 90.8 
  2 84.2 74.2 90.8 
 NoGo 1 95.4 80.8 99.2 
  2 96.3 87.5 98.3 
Note. *Significant differences between children with ADHD and control children in 
corresponding conditions; n.s., no significant differences between the two groups in 
corresponding conditions. Table adapted with permission from Paul-Jordanov et al. (2010). 
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Table 7.2 
Reaction Time Results (Go Trials) for the ADHD and Control Groups in Germany 
Group Session Mean RT (ms) 
95% CI 
Lower boundary 
95% CI 
Upper boundary 
ADHD Unmedicated/1 656.26* 598.68 713.84 
 Medicated/2 584.96 n.s. 537.35 632.56 
Control 1 542.96 497.43 588.48 
 2 538.93 501.30 576.57 
Note. RT = reaction time; CI = confidence interval. *Significant differences between 
children with ADHD and control children in corresponding conditions; n.s., no significant 
differences between the two groups in corresponding conditions. Table adapted with 
permission from Paul-Jordanov et al. (2010). 
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Table 7.3 
Sample Characteristics in Taiwan in Study 2 
Variable 
ADHD 
Mean ± SD 
Controls 
Mean ± SD 
Statistics 
t value p value 
 (N = 10) (N = 14)   
Age (years) 9.86 ± 1.05 10.25 ± 0.88 -0.99 .333 
Male, n (%) 8 (80.0) 13 (92.9)   
Medication naïve, n (%) 2(20.0) --   
Right handedness, n (%) 10 (100.0) 13 (92.9)   
CBCL – mother report (T score) (N = 9) (N = 12)   
 Aggressive behavior 65.27 ± 16.50 46.73 ± 8.50 3.08 .010 
 Anxious/Depressed 65.89 ± 18.12 48.94 ± 8.04 2.62 .025 
 Attention problems 64.61 ± 10.55 41.60 ± 4.14 6.20 < .001 
 Delinquent behavior 57.78 ± 12.19 45.95 ± 3.25 2.84 .020 
 Social problems 62.33 ± 12.91 46.96 ± 6.08 3.31 .007 
 Somatic complaints 51.30 ± 12.39 45.34 ± 5.87 1.47 .158 
 Thought problems 72.32 ± 22.01 45.68 ± 6.03 3.53 .006 
 Withdrawn 53.72 ± 14.42 44.90 ± 5.75 1.94 .068 
 Internalizing problems 59.83 ± 16.07 46.27 ± 7.32 2.36 .039 
 Externalizing problems 64.09 ± 15.42 46.34 ± 6.21 3.26 .009 
SNAP-IV – mother report 
(T score) 
(N = 9) (N = 13)   
 Total score 57.23 ± 7.11 44.73 ± 4.45 5.09 < .001 
 Inattention 57.07 ± 8.86 45.90 ± 5.28 3.71 .001 
 Hyperactivity/ Impulsivity 55.46 ± 5.18 45.28 ± 3.76 5.36 < .001 
 Oppositional defiant disorder 54.29 ± 14.90 42.65 ± 5.10 2.26 .050 
Note. SD = standard deviation; CBCL = Child Behavior Checklist.  
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Figure 7.1 Differences on reaction times to Go trials between the ADHD and control groups 
in Taiwan. 
 
Figure 7.2 Differences on the rates of correct Go trials between the ADHD and control 
groups in Taiwan. 
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Table 7.4 
Behavioral Results (Reaction Times on Go Trials; % Correct Go Responses) for the ADHD 
and Control Groups in Taiwan 
Variable 
(Mean ± SD) 
1
st
 session 2
nd
 session 
Statistics 
t value  p value Cohen’s d 
ADHD      
 Go RT (ms) 694.79 ± 68.25 671.26 ± 90.87 1.63 .138 0.51 
 
Correct  
Go trials (%) 
62.66 ± 14.18 68.63 ± 12.73 -3.18 .011 1.01 
Controls      
 Go RT (ms) 630.53 ± 64.30 624.84 ± 72.33 0.39 .706 0.10 
 
Correct 
Go trials (%) 
81.77 ± 8.83 82.11 ± 11.25 -0.14 .893 0.04 
Note. SD = standard deviation; RT = reaction time. 
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Table 7.5 
Results of Rates of Correct Inhibitions after NoGo Sign for the ADHD and Control Groups 
in Taiwan 
Group Variable 1
st
 session 2
nd
 session Statistic p value 
ADHD Median (%)  95.56 98.75 Z = -1.02 .308 
 Minimum (%) 85.56 85.83   
 Maximum (%) 100.00 100.00   
Controls Median (%) 97.07 99.17 Z = -1.735 .083 
 Minimum (%) 90.83 90.83   
 Maximum (%) 100.00 100.00   
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7.4 Discussion 
In Germany, medication has proven effective in enhancing the rates of correct NoGo 
trials and decreasing reaction times to Go trials in children with ADHD, while significant 
differences on the rates of correct Go trials were still observed between the medicated 
children with ADHD and non-ADHD children (source from Paul-Jordanov et al., 2010 and 
see Paul-Jordanov et al., 2010 for more detailed discussion).  
Similarly, in Taiwan, the ADHD and control groups were compatible on reaction 
times to Go trials, but not on the rates of correct Go trials in the second (medicated) session. 
A significant difference was observed between medicated children with ADHD and healthy 
children on the rate of correct Go trials. However, we found that children with ADHD 
displayed higher rates of correct Go trials in Session 2 (with medication) than in Session 1 
(without medication), with a large effect size. As the efficacy of MPH persists over one year 
(The MTA Cooperative Group, 1999a), these results may indicate that MPH is effective to 
some extent in improving children’s responses on Go trials—and that children with ADHD 
need a period of time in order to reach the same behavioral performance as normally 
developing children (Konrad, Neufang, Fink, & Herpertz-Dahlmann, 2007). This could 
explain that, after an interval of approximately 30 days, a significant difference was still 
observed between medicated children with ADHD and non-ADHD children in terms of the 
rate of correct Go trials. 
Additionally, children with ADHD did not differ from controls regarding reaction 
times to Go trials in the second (medicated) session. Children with ADHD tended to 
respond to Go trials more quickly when on medication than when off medication, but the 
difference between sessions was non-significant. The effect size is moderate, which may 
indicate that MPH is effective in enhancing alertness (e.g., shorter reaction times) in ADHD 
to some extent (also see Chapter 8 for more detailed discussion). 
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With respect to the rates of correct NoGo trials, no significant differences between 
the ADHD and control groups in the Taiwanese sample were observed in the first 
(unmedicated) and second (medicated) sessions. No significant within-group differences 
were found for both ADHD and control groups (see Chapter 8 for more detailed discussion). 
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8. General Discussion and Implications for Future Research 
Incorporating the data from the previous study (Paul-Jordanov et al., 2010), the 
current research is an initial attempt to investigate response inhibition among children with 
ADHD and normally developing children in Germany and Taiwan, using the same study 
design and task. Moreover, it explores the effect of MPH on response inhibition among 
children with ADHD at both sites. In this chapter, discussion is focused more on the results 
from the Taiwanese sample and the inconsistent findings with those observed in the German 
sample (please refer to Paul-Jordanov et al., 2010 regarding the discussion on the German 
sample). 
8.1 Response Inhibition in ADHD 
Consistent with the previous studies (Fallgatter et al., 2004; Gawrilow & Gollwitzer, 
2008), unmedicated children with ADHD at both sites responded to Go trials less accurately 
(i.e., lower rates on correct Go trials) and more slowly (i.e., longer reaction times to Go 
trials) than did their non-ADHD counterparts (both Studies 1 and 2) (see Paul-Jordanov et 
al., 2010 for detailed discussion regarding the results from the German sample).  
Findings at both sites may reflect that children with ADHD are impaired in selective 
attention and alertness (Fallgatter et al., 2004). The finding of decreased rates on correct 
NoGo trials (i.e., a failure to inhibit responses) in the unmedicated ADHD group in 
Germany (Paul-Jordanov et al., 2010) could not be replicated in the Taiwanese sample. This 
is because we found that, prior to the treatment of medication, Taiwanese children with 
ADHD exhibited equal rates on correct NoGo trials as healthy children (both Studies 1 and 
2). This observation in the Taiwanese sample, however, is in line with the previous research 
that reported no significant group differences in child (Fallgatter et al., 2004) and adult 
(Dresler et al., 2010) populations with respect to inhibitory control. The mixed findings may 
indicate that deficits in response control, rather than a specific deficit in inhibition per se, 
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exist in ADHD (Fallgatter et al., 2004). These findings also support the earlier research, 
which demonstrated that ADHD is heterogeneous in etiology as a proportion of children 
with ADHD are impaired in other neuropsychological functions (e.g., delay aversion or 
sustained attention) rather than in behavioral inhibition (de Zeeuw, Weusten, Dijk, van 
Belle, & Durston, 2012).  
The discrepancy observed between the German and Taiwanese samples with respect 
to the rate of correct NoGo trials could be accounted for by the following possibilities. First, 
the two studies, to our knowledge, are the first studies to apply the Go/NoGo task used by 
Paul-Jordanov et al. (2010) and Paul et al. (2007) in an ethnic group quite different from the 
German sample. Therefore, we speculate that according to Meyer (2005), cultural factors 
may account in part for the discrepancy in inhibition observed between the two ethnic 
groups because:  
….cultural differences do affect the performance on neuropsychological measures. 
The reason may be that cultural factors are important for determinants of child 
rearing practices which may affect the brain’s organization of cognition. There is 
therefore a need for assessment methods that are culturally valid for different ethnic 
groups. (p. 105) 
For example, previous studies have suggested that parenting makes critical contributions to 
the development of executive functioning and the expression of ADHD behaviors (Blair, 
Raver, & Berry, 2014; Blair et al., 2011; Hammond, Müller, Carpendale, Bibok, & 
Liebermann-Finestone, 2012; Nikolas, Klump, & Burt, 2015), and thus it would be valuable 
to include relevant information regarding parenting to investigate whether parenting style 
plays a potential role in moderating children’s behavioral performances on the Go/NoGo 
task (e.g., making children more inhibited or less inhibited). 
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Second, as suggested by Klorman (1991), deficient behavioral performance and 
abnormal electrophysiological components manifested by children with ADHD are more 
evident while they are performing difficult and demanding tasks. One study (Huizenga, van 
Bers, Plat, van den Wildenberg, & van der Molen, 2009) also demonstrated that inhibitory 
dysfunction is more pronounced in children and adolescents with ADHD for relatively 
complex tasks. Accordingly, the Go/NoGo task used in these present studies could be less 
demanding for participants in Taiwan, accounting for why there was no significant 
difference between children with ADHD and healthy controls on the correct rates of NoGo 
trials. Another possibility could be that a ceiling effect existed for groups. However, these 
speculations should be treated with caution due to the limited sample size. Thus, future 
research with a larger sample size and with various task difficulties is required to investigate 
these speculations more fully. 
Third, some earlier research (Groom et al., 2008; A. Smith et al., 2006) has 
demonstrated that aberrant performance manifested by clinical patients may be observed at 
the electrophysiological level linked to brain activation, but not at the behavioral level (i.e., 
the behavioral performance of clinical patients is equivalent to or not significantly different 
from that of healthy individuals). Accordingly, despite the existence of no significant group 
difference in response inhibition (i.e., the rates of correct NoGo trials) in the Taiwanese 
sample at the behavioral level, it cannot be fully ascertained that no deficient inhibitory 
control exists among children with ADHD in Taiwan. As ―brain activation measures may be 
more sensitive to abnormalities than performance‖ (A. Smith et al., 2006, p. 1049), more 
investigations from electrophysiological or neuroimaging studies with the same Go/NoGo 
task (Paul-Jordanov et al., 2010) would be helpful to clarify this finding. 
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8.2 The Effect of MPH on Response Inhibition in ADHD 
After the treatment of medication, children with ADHD in Germany continued to 
exhibit lower rates of correct Go trials than their healthy counterparts, but no significant 
group differences were observed on reaction times during Go trials. In addition, the rates of 
correct NoGo trials did not differ markedly between medicated children with ADHD and 
non-ADHD controls (i.e., both groups were equally successful at inhibiting responses on 
NoGo trials) (source from Paul-Jordanov et al., 2010). Similarly, for the Taiwanese sample, 
significant group differences in the second (medicated) session were found on the rates of 
correct Go trials, but not on the reaction times on Go trials. Also, medicated ADHD 
children did not significantly differ from controls in terms of response inhibition, as the 
rates of correct NoGo trials were equal between the two groups. 
In the German sample, within-subject comparisons between sessions showed that 
children with ADHD did not display significant differences on the rates of correct Go trials 
and of correct NoGo trials, but showed a significant difference on reaction times during Go 
trials (source from Paul-Jordanov et al., 2010). In the Taiwanese sample, within-subject 
comparisons between sessions showed that children with ADHD displayed a significant 
difference on the rate of correct Go trials, but showed no significant differences on reaction 
times during Go trials and the rate of correct NoGo trials. These differences could be 
explained by the difference in treatment duration or response to medication. Additionally, 
medication may have differential effects on different ethnic groups or populations, which 
could result from the difference in genetic background between the German and Taiwanese 
samples (McGough et al., 2006). Regarding this speculation, future cross-cultural studies 
will be needed to extend our understanding by exploring shared and group-specific effects 
of MPH on ADHD. 
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Specifically, in the Taiwanese sample, within-subject comparisons showed that 
children with ADHD appeared to benefit from MPH in terms of the rate of correct Go trials, 
even though the enhancement did not allow children with ADHD to reach the same 
performance as non-ADHD children did (e.g., no significant group difference between 
medicated ADHD children and non-ADHD children). As highlighted by the MTA 
cooperative groups (1999a), ―Statistical significance, of course, cannot be interpreted as 
necessarily indicative of clinical or practical significance, and lack of significance is ever 
proof of the equivalency of treatments‖ (p.1083). Accordingly, the finding of the large 
effect size may indicate that MPH is effective in improving ADHD children’s responses 
regarding the rate of correct Go trials, but children with ADHD may need a certain period of 
time in order to reach the same level as controls (Konrad et al., 2007). With respect to the 
efficacy of MPH on ADHD over time, future research with extended study periods will help 
to explore the long-term efficacy of MPH on response inhibition measured by this Go/NoGo 
task in ADHD. 
Regarding reaction times in Go trials, children with ADHD did not display 
significant differences between sessions (i.e., without medication and with medication), but 
a medium-sized effect existed between sessions. Along with the finding that children with 
ADHD did not differ pronouncedly from controls in the second (medicated) session, it may 
indicate that MPH is effective to some extent in reaction times during Go trials. Likewise, 
studies with larger sample sizes are needed to clarify this observation. 
With respect to the inhibition-related index (i.e., the rate of correct NoGo trials), 
children with ADHD did not significantly differ from non-ADHD children in the second 
(medicated) session, as observed in the first (unmedicated) session. Within-subject 
comparisons showed no pronounced differences between sessions for both groups. The 
finding of no significant MPH effect on inhibition in ADHD in the Taiwanese sample could 
76 
be explained by the hypothesis of baseline-dependent effects of psychostimulants (Eagle et 
al., 2008)—that is, patients with worse baseline performances improve more regarding 
commission errors after the treatment with psychostimulants. Also, as pointed out by Eagle 
et al. (2008, p.448), ―In up to 30% of ADHD cases, methylphenidate fails to improve or 
even worsens symptoms such as deficient action inhibition (Cantwell, 1996; Krause et al., 
2005), perhaps because MPH only improves deficient action inhibition in the cases that 
have the most pronounced action-inhibition deficits.‖ As, prior to stimulant treatment, no 
significant group difference in inhibition was observed between children with ADHD and 
non-ADHD controls in the Taiwanese sample (see Studies 1 and 2), it is speculated that 
most children in the ADHD group may have less symptom severity. Instead of taking the 
sample as a whole, future research investigating the effect of MPH on inhibition in 
subgroups exhibiting different levels of symptom severity will be helpful in clarifying the 
speculation and observation. 
8.3 Limitations of the Current Research 
Although the current research advances the literature on the effect of medication on 
response inhibition in children with ADHD, several limitations remain. First, we did not 
control for comorbid disorders, intelligence, and the severity of ADHD at both sites. These 
factors could lead to different interpretations of the current results, as they moderate the 
association between ADHD and executive functioning, and thus affect children’s behavioral 
performance during inhibition tasks (The MTA Cooperation Group, 1999b; Willcutt et al., 
2005). Second, the small age ranges of the samples at both sites—between approximately 8 
and 12 years—and the sample composition (i.e., mostly male participants at both sites) may 
hamper the generalization of the current findings to other age or gender groups (The MTA 
Cooperative Group, 1999b). Third, and most importantly, the small sample sizes both in 
Germany and Taiwan may preclude a definitive statement for the present research.  
77 
9. Implications for Clinical Practice and Conclusion 
9.1 Implications for Clinical Practice 
Currently, clinicians and practitioners follow the criteria of the DSM or ICD system 
regarding the diagnosis of ADHD. They may partly rely on parental reports regarding 
children’s behaviors and refer to children’s performance on neuropsychological tasks (e.g., 
CPT) during the diagnosis period. The current research brings our attention to the potential 
role of culture on children’s performance during neuropsychological tasks, and even on the 
patterns of parent-rated reports. As discussed earlier, children with ADHD may manifest 
differential deficient behavioral patterns during neuropsychological tasks due to the 
heterogeneity of ADHD and/or the influence of parenting practices on children’s behaviors.  
Parental reports on children’s behaviors may be influenced by personal 
characteristics (Olson et al., 2011) or biased by culture (Thorell, Veleiro, Siu, & 
Mohammadi, 2013). For instance, a cross-cultural study conducted by Thorell et al. (2013) 
found that, relative to other samples (i.e., Sweden, Spain, and Iran), Chinese children aged 
6-11 years were rated as having more executive functioning deficits, which could result 
from cultural bias. Moreover, prior research has demonstrated that professionals across 
countries display variations in rating hyperactive-disruptive behaviors, even though 
identical criteria are applied (Mann et al., 1992). Based on these observations, it may be 
valuable to explore the culture-specific behavioral patterns in ADHD in addition to the 
commonly-observed impaired symptoms, particularly during a specific neuropsychological 
task, across cultures. Also, as parental perceptions of children’s behaviors (e.g., the 
presence and extent of hyperactive behaviors) vary across cultures, understanding parental 
response patterns or characteristics when rating ADHD-related behaviors would be helpful 
for clinical practices during the diagnosis of ADHD. 
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With respect to the management of ADHD, even though medication is shown to be 
superior in improving the core symptoms of ADHD, multimodal and behavioral treatments 
may be effective for some domains, e.g., academic performance, social skills (The MTA 
Cooperative Group, 1999a, 1999b). In addition, several factors (e.g., gender, previous 
medication treatment, comorbid disorders, and treatment acceptance) are reported to be 
related to the treatment effect across outcome domains. As highlighted by Hinshaw and 
Arnold (2015), it is important to consider relevant moderators or mediators involved in 
differential patterns of outcomes during the treatment period. Moreover, differential 
response patterns after the treatment of medication, and the extent to which medication 
exerts its effect on ADHD, may vary across cultures or countries. Consequently, 
understanding the potential factors related to the treatment effect and response patterns, and 
characteristics across cultures, would be of great help for clinicians and practitioners to 
effectively manage not only ADHD symptoms but also associated dysfunctional behaviors. 
ADHD is presently viewed as a chronic disorder. The long-term effectiveness of the 
treatments remains unclear, although the short-term effectiveness of medication and 
behavioral treatments has been clearly demonstrated (Hinshaw & Arnold, 2015). Therefore, 
it would be compelling to explore the long-term effectiveness of the treatments (e.g., 
pharmacological treatment, behavioral intervention, and combined treatment) on ADHD 
and how different types of treatments interact with psychosocial factors (e.g., maternal 
characteristics, family functioning, parent-child relationship) on the development of ADHD 
and other behaviors (e.g., aggressive and disruptive behaviors). 
In addition to the treatment of medication, clinicians and practitioners may apply 
behavioral strategies on the management of ADHD. As indicated by Oettingen, Sevincer, 
and Gollwitzer (2008), the context of socio-culture may have a potential impact on the 
effect of forming behavioral strategies. Hence, it would be worthwhile to consider the extent 
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to which a specific behavioral strategy is applied in one cultural setting and the differential 
effects it has on ADHD symptoms and associated functioning. Also, clinicians and 
practitioners need to help children with ADHD and their parents learn and consolidate their 
skills and apply behavioral strategies in daily life in order to obtain long-lasting benefits 
(The MTA Cooperative Group, 1999a). 
Finally, the ―one size fits all‖ approach (The MTA Cooperative Group, 1999a, 
p.1083) may not be appropriate for the treatment of ADHD across cultures, or even within 
one cultural setting. The current research and previous findings (e.g., The MTA Cooperative 
Group, 1999b) highlight the impacts of culture, moderators, and mediators on the treatment 
of ADHD. Considering these potential influential factors on the diagnosis and management 
of ADHD would lead clinicians and psychiatrists to offer more effective and client-based 
treatments for ADHD. 
9.2 Conclusion 
To summarize, this is the first research that used the identical inhibition task 
paradigm to explore the effect of MPH on behavioral performance in children with ADHD 
in Germany and Taiwan. The current findings, in accordance with previous studies (Broyd 
et al., 2005), may indicate that MPH is effective in ameliorating deficient response 
inhibition (shown in the German sample) and other behavioral performances (shown both in 
the German and Taiwanese samples). However, future studies investigating psychosocial 
factors on the development and prognosis of ADHD would be helpful for the management 
of this disorder and other associated functioning. Finally, we expect that future studies with 
larger sample sizes or more evidence from studies using electrophysiological (e.g., EEG) or 
imaging techniques (e.g., fMRI) will confirm the present observations to better reveal the 
underlying mechanism in ADHD and the effects of medication on this disorder. 
  
80 
  
81 
10. References 
Achenbach, T. M. (1991). Mannual for the child behavior checklist/4-18 and 1991 profile. 
Burlington: Department of Psychiatry, University of Vermont. 
Abikoff, H., Hechtman, L., Klein, R. G., Weiss, G., Fleiss, K., Etcovitch, J. O. Y., . . . 
Pollack, S. (2004). Symptomatic improvement in children with ADHD treated with 
long-term methylphenidate and multimodal psychosocial treatment. Journal of the 
American Academy of Child and Adolescent Psychiatry, 43, 802-811. 
Albrecht, B., Banaschewski, T., Brandeis, D., Heinrich, H., & Rothenberger, A. (2005). 
Response inhibition deficits in externalizing child psychiatric disorders: an ERP-
study with the Stop-task. Behavioral and Brain Functions, 1, 22. 
Alderson, R. M., Rapport, M. D., & Kofler, M. J. (2007). Attention-deficit/hyperactivity 
disorder and behavioral inhibition: A meta-analytic review of the stop-signal 
paradigm. Journal of Abnormal Child Psychology, 35, 745-758. 
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental 
disorders DSM-IV-TR. Washington, D.C.: Author. 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders (5th ed.). Washington, DC: Author. 
Anderson, C. A., Hinshaw, S. P., & Simmel, C. (1994). Mother-child interactions in ADHD 
and comparison boys: Relationships with overt and covert externalizing behavior. 
Journal of Abnormal Child Psychology, 22, 247-265. 
Arbeitsgruppe Deutsche Child Behavior Checklist (1998). Elternfragebogen ueber das 
Verhalten von Kindern und Jugendlichen; deutsche Bearbeitung der Child Behavior 
Checklist (CBCL/4-18). Einfuehrung und Anleitung zur Handauswertung. 2. Auflage 
mit deutschen Normen, bearbeitet von M. Doepfner, J. Plueck, S. Boelte, K. Lenz, P. 
82 
Melchers, & K. Heim Koeln: Arbeitsgruppe Kinder-, Jugend- und 
Familiendiagnostik (KJFD). 
Aron, A. R., Dowson, J. H., Sahakian, B. J., & Robbins, T. W. (2003). Methylphenidate 
improves response inhibition in adults with attention-deficit/hyperactivity disorder. 
Biological Psychiatry, 54, 1465-1468. 
August, G. J., Realmuto, G. M., MacDonald, A. W., Nugent, S. M., & Crosby, R. (1996). 
Prevalence of ADHD and comorbid disorders among elementary school children 
screened for disruptive behavior. Journal of Abnormal Child Psychology, 24, 571-
595. 
Aylward, E. H., Reiss, A. L., Reader, M. J., Singer, H. S., Brown, J. E., & Denckla, M. B. 
(1996). Basal ganglia volumes in children with attention-deficit hyperactivity 
disorder. Journal of Child Neurology, 11, 112-115. 
Banaschewski, T., Becker, K., Scherag, S., Franke, B., & Coghill, D. (2010). Molecular 
genetics of attention-deficit/hyperactivity disorder: an overview. European Child 
and Adolescent Psychiatry, 19, 237-257. 
Banaschewski, T., Brandeis, D., Heinrich, H., Albrecht, B., Brunner, E., & Rothenberger, A. 
(2004). Questioning inhibitory control as the specific deficit of ADHD--evidence 
from brain electrical activity. Journal of Neural Transmission, 111, 841-864. 
Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: 
constructing a unifying theory of ADHD. Psychological Bulletin, 121, 65-94. 
Barkley, R. A. (2004). Adolescents with attention-deficit/hyperactivity disorder: an 
overview of empirically based treatments. Journal of Psychiatric Practice, 10, 39-56. 
Barkley, R. A. (2010). Differential diagnosis of adults with ADHD: the role of executive 
function and self-regulation. The Journal of Clinical Psychiatry, 71, e17. 
83 
Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1990). Comprehensive evaluation of 
attention deficit disorder with and without hyperactivity as defined by research 
criteria. Journal of Consulting and Clinical Psychology, 58, 775-789. 
Bayer, U. C., Achtziger, A., Gollwitzer, P. M., & Moskowitz, G. B. (2009). Responding to 
subliminal cues: Do if-then plans facilitate action preparation and initiation without 
conscious intent? Social Cognition, 27, 183-201. 
Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., . . . Johnson, M. 
A. (2002). Influence of gender on attention deficit hyperactivity disorder in children 
referred to a psychiatric clinic. The American Journal of Psychiatry, 159, 36-42. 
Blair, C., Raver, C. C., & Berry, D. J. (2014). Two approaches to estimating the effect of 
parenting on the development of executive function in early childhood. 
Developmental Psychology, 50, 554-565. 
Blair, C., Willoughby, M., Greenberg, M. T., Kivlighan, K. T., Fortunato, C. K., Granger, D. 
A., . . . Investigators, F. L. P. (2011). Salivary cortisol mediates effects of poverty 
and parenting on executive functions in early childhood. Child Development, 82, 
1970-1984. 
Bokura, H., Yamaguchi, S., & Kobayashi, S. (2001). Electrophysiological correlates for 
response inhibition in a Go/NoGo task. Clinical Neurophysiology, 112, 2224-2232. 
Boonstra, A. M., Kooij, J. J., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2005). Does 
methylphenidate improve inhibition and other cognitive abilities in adults with 
childhood-onset ADHD? Journal of Clinical and Experimental Neuropsychology, 
27, 278-298. 
Boonstra, A. M., Kooij, J. J., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2010). To 
act or not to act, that's the problem: primarily inhibition difficulties in adult ADHD. 
Neuropsychology, 24, 209-221. 
84 
Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz, M., & 
Lawrence, C. A. (2005). The effect of methylphenidate on response inhibition and 
the event-related potential of children with attention deficit/hyperactivity disorder. 
International Journal of Psychophysiology, 58, 47-58. 
Burgio-Murphy, A., Klorman, R., Shaywitz, S. E., Fletcher, J. M., Marchione, K. E., 
Holahan, J., . . . Shaywitz, B. A. (2007). Error-related event-related potentials in 
children with attention-deficit hyperactivity disorder, oppositional defiant disorder, 
reading disorder, and math disorder. Biological Psychology, 75, 75-86. 
Bush, G. (2011). Cingulate, frontal, and parietal cortical dysfunction in attention-
deficit/hyperactivity disorder. Biological Psychiatry, 69, 1160-1167. 
Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A., . . . 
Biederman, J. (1999). Anterior cingulate cortex dysfunction in attention-
deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biological 
Psychiatry, 45, 1542-1552. 
Casey, B. J., Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Schubert, A. 
B., . . . Rapoport, J. L. (1997). Implication of right frontostriatal circuitry in response 
inhibition and attention-deficit/hyperactivity disorder. Journal of the American 
Academy of Child and Adolescent Psychiatry, 36, 374-383. 
Castellanos, F. X., Lee, P. P., Sharp, W., Jeffries, N. O., Greenstein, D. K., Clasen, L. S., . . . 
Rapoport, J. L. (2002). Developmental trajectories of brain volume abnormalities in 
children and adolescents with attention-deficit/hyperactivity disorder. Journal of the 
American Medical Association, 288, 1740-1748. 
Chamberlain, S. R., Del Campo, N., Dowson, J., Muller, U., Clark, L., Robbins, T. W., & 
Sahakian, B. J. (2007). Atomoxetine improved response inhibition in adults with 
attention deficit/hyperactivity disorder. Biological Psychiatry, 62, 977-984. 
85 
Chamberlain, S. R., Hampshire, A., Muller, U., Rubia, K., Del Campo, N., Craig, K., . . . 
Sahakian, B. J. (2009). Atomoxetine modulates right inferior frontal activation 
during inhibitory control: a pharmacological functional magnetic resonance imaging 
study. Biological Psychiatry, 65, 550-555. 
Cheie, L., Veraksa, A., Zinchenko, Y., Gorovaya, A., & Visu-Petra, L. (2015). A cross-
cultural investigation of inhibitory control, generative fluency, and anxiety 
symptoms in Romanian and Russian preschoolers. Child Neuropsychology, 21, 121-
149. 
Chen, C. K., Chen, S. L., Mill, J., Huang, Y. S., Lin, S. K., Curran, S., . . . Asherson, P. 
(2003). The dopamine transporter gene is associated with attention deficit 
hyperactivity disorder in a Taiwanese sample. Molecular Psychiatry, 8, 393-396. 
Chen, X., Cen, G., Li, D., & He, Y. (2005). Social functioning and adjustment in Chinese 
children: the imprint of historical time. Child Development, 76, 182-195. 
Chronis, A. M., Lahey, B. B., Pelham, W. E. Jr., Williams, S. H., Baumann, B. L., Kipp, 
H., . . . Rathouz, P. J. (2007). Maternal depression and early positive parenting 
predict future conduct problems in young children with attention-
deficit/hyperactivity disorder. Developmental Psychology, 43, 70-82. 
Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159. 
Cubillo, A., Halari, R., Ecker, C., Giampietro, V., Taylor, E., & Rubia, K. (2010). Reduced 
activation and inter-regional functional connectivity of fronto-striatal networks in 
adults with childhood attention-deficit hyperactivity disorder (ADHD) and persisting 
symptoms during tasks of motor inhibition and cognitive switching. Journal of 
Psychiatric Research, 44, 629-639. 
Cubillo, A., Halari, R., Smith, A., Taylor, E., & Rubia, K. (2012). A review of fronto-
striatal and fronto-cortical brain abnormalities in children and adults with attention 
86 
deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults 
with ADHD during motivation and attention. Cortex, 48, 194-215. 
de Zeeuw, P., Weusten, J., Dijk, S. v., van Belle, J., & Durston, S. (2012). Deficits in 
cognitive control, timing and reward sensitivity appear to be dissociable in ADHD. 
PLoS One, 7, e51416. 
Deault, L. (2010). A systematic review of parenting in relation to the development of 
comorbidities and functional impairments in children with attention-
deficit/hyperactivity disorder (ADHD). Child Psychiatry and Human Development, 
41, 168-192. 
Dichter, G. S., van der Stelt, O., Boch, J. L., & Belger, A. (2006). Relations among 
intelligence, executive function, and P300 event related potentials in schizophrenia. 
Journal of Nervous and Mental Disease, 194, 179-187. 
Dimoska, A., Johnstone, S. J., Barry, R. J., & Clarke, A. R. (2003). Inhibitory motor control 
in children with attention-deficit/hyperactivity disorder: event-related potentials in 
the stop-signal paradigm. Biological Psychiatry, 54, 1345-1354. 
Doehnert, M., Brandeis, D., Imhof, K., Drechsler, R., & Steinhausen, H. C. (2010). 
Mapping attention-deficit/hyperactivity disorder from childhood to adolescence--no 
neurophysiologic evidence for a developmental lag of attention but some for 
inhibition. Biological Psychiatry, 67, 608-616. 
Doepfner, M., Breuer, D., Wille, N., Erhart, M., & Ravens-Sieberer, U. (2008). How often 
do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder 
and hyperkinetic disorder? Parent-based prevalence rates in a national sample – 
results of the BELLA study. European Child and Adolescent Psychiatry, 17, 59-70. 
Dresler, T., Ehlis, A.-C., Heinzel, S., Renner, T. J., Reif, A., Baehne, C. G., . . . Fallgatter, A. 
J. (2010). Dopamine transporter (SLC6A3) genotype impacts neurophysiological 
87 
correlates of cognitive response control in an adult sample of patients with ADHD. 
Neuropsychopharmacology, 35, 2193-2202. 
Eagle, D. M., Bari, A., & Robbins, T. W. (2008). The neuropsychopharmacology of action 
inhibition: cross-species translation of the stop-signal and go/no-go tasks. 
Psychopharmacology (Berl), 199, 439-456. 
Egan, M. F., Duncan, C. C., Suddath, R. L., Kirch, D. G., Mirsky, A. F., & Wyatt, R. J. 
(1994). Event-related potential abnormalities correlate with structural brain 
alterations and clinical features in patients with chronic schizophrenia. 
Schizophrenia Research, 11, 259-271. 
Entwisle, D. R., Alexander, K. L., & Olson, L. S. (2007). Early schooling: the handicap of 
being poor and male. Sociology of Education, 80, 114-138. 
Epstein, J. N., Johnson, D. E., Varia, I. M., & Conners, C. K. (2001). Neuropsychological 
assessment of response inhibition in adults with ADHD. Journal of Clinical and 
Experimental Neuropsychology, 23, 362-371. 
Epstein, J. N., Langberg, J. M., Rosen, P. J., Graham, A., Narad, M. E., Antonini, T. N., . . . 
Altaye, M. (2011). Evidence for higher reaction time variability for children with 
ADHD on a range of cognitive tasks including reward and event rate manipulations. 
Neuropsychology, 25, 427-441. 
Falkenstein, M., Hoormann, J., & Hohnsbein, J. (1999). ERP components in Go/Nogo tasks 
and their relation to inhibition. Acta Psychologica, 101, 267-291. 
Fallgatter, A. J., Ehlis, A. C., Rosler, M., Strik, W. K., Blocher, D., & Herrmann, M. J. 
(2005). Diminished prefrontal brain function in adults with psychopathology in 
childhood related to attention deficit hyperactivity disorder. Psychiatry Research, 
138, 157-169. 
88 
Fallgatter, A. J., Ehlis, A. C., Seifert, J., Strik, W. K., Scheuerpflug, P., Zillessen, K. E., . . . 
Warnke, A. (2004). Altered response control and anterior cingulate function in 
attention-deficit/hyperactivity disorder boys. Clinical Neurophysiology, 115, 973-
981. 
Fallgatter, A. J., & Strik, W. K. (1999). The NoGo-anteriorization as a neurophysiological 
standard-index for cognitive response control. International Journal of 
Psychophysiology, 32, 233-238. 
Faraone, S. V., Doyle, A. E., Mick, E., & Biederman, J. (2001). Meta-analysis of the 
association between the 7-repeat allele of the dopamine D4 receptor gene and 
attention deficit hyperactivity disorder. The American Journal of Psychiatry, 158, 
1052-1057. 
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., 
& Sklar, P. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. 
Biological Psychiatry, 57, 1313-1323. 
Faraone, S. V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide 
prevalence of ADHD: is it an American condition? World Psychiatry, 2, 104-113. 
Fisher, T., Aharon-Peretz, J., & Pratt, H. (2011). Dis-regulation of response inhibition in 
adult attention deficit hyperactivity disorder (ADHD): an ERP study. Clinical 
Neurophysiology, 122, 2390-2399. 
Fuster, J. M. (1993). Frontal lobes. Current Opinion in Neurobiology, 3, 160-165. 
Garavan, H., Ross, T. J., Murphy, K., Roche, R. A., & Stein, E. A. (2002). Dissociable 
executive functions in the dynamic control of behavior: inhibition, error detection, 
and correction. Neuroimage, 17, 1820-1829. 
89 
Garavan, H., Ross, T. J., & Stein, E. A. (1999). Right hemispheric dominance of inhibitory 
control: an event-related functional MRI study. Proceedings of the National 
Academy of Sciences of the United States of America, 96, 8301-8306. 
Gau, S. S. (2007). Parental and family factors for attention-deficit hyperactivity disorder in 
Taiwanese Children. Australian and New Zealand Journal of Psychiatry, 41, 688-
696. 
Gau, S. S., Chiu, C. D., Shang, C. Y., Cheng, A. T., & Soong, W. T. (2009). Executive 
function in adolescence among children with attention-deficit/hyperactivity disorder 
in Taiwan. Journal of Developmental and Behavioral Pediatrics, 30, 525-534. 
Gau, S. S., Chong, M. Y., Chen, T. H., & Cheng, A. T. (2005). A 3-year panel study of 
mental disorders among adolescents in Taiwan. The American Journal of Psychiatry, 
162, 1344-1350. 
Gau, S. S., Huang, Y. S., Soong, W. T., Chou, M. C., Chou, W. J., Shang, C. Y., . . . Lee, P. 
(2007). A randomized, double-blind, placebo-controlled clinical trial on once-daily 
atomoxetine in Taiwanese children and adolescents with attention-
deficit/hyperactivity disorder. Journal of Child and Adolescent 
Psychopharmacology, 17, 447-460. 
Gau, S. S., Lin, Y. J., Shang, C. Y., Liu, S. K., & Chiu, Y. N. (2010). Emotional/behavioral 
problems and functional impairment in clinic- and community-based children with 
attention-deficit/hyperactivity disorder in Taiwan. Journal of Abnormal Child 
Psychology, 38, 521-32. 
Gau, S. S., Ni, H. C., Shang, C. Y., Soong, W. T., Wu, Y. Y., Lin, L. Y., & Chiu, Y. N. 
(2010). Psychiatric comorbidity among children and adolescents with and without 
persistent attention-deficit hyperactivity disorder. Australian and New Zealand 
Journal of Psychiatry, 44, 135-143. 
90 
Gau, S. S., Shen, H. Y., Soong, W. T., & Gau, C. S. (2006). An open-label, randomized, 
active-controlled equivalent trial of osmotic release oral system methylphenidate in 
children with attention-deficit/hyperactivity disorder in Taiwan. Journal of Child 
and Adolescent Psychopharmacology, 16, 441-455. 
Gawrilow, C., & Gollwitzer, P. (2008). Implementation intentions facilitate response 
inhibition in children with ADHD. Cognitive Therapy and Research, 32, 261-280. 
Gawrilow, C., Gollwitzer, P. M., & Oettingen, G. (2011). If-then plans benefit executive 
functions in children with ADHD. Journal of Social and Clinical Psychology, 30, 
616-646. 
Giedd, J. N., Castellanos, F. X., Casey, B. J., Kozuch, P., King, A. C., Hamburger, S. D., & 
Rapoport, J. L. (1994). Quantitative morphology of the corpus callosum in attention 
deficit hyperactivity disorder. The American Journal of Psychiatry, 151, 665-669. 
Goldman, L. S., Genel, M., Bezman, R. J., & Slanetz, P. J. (1998). Diagnosis and treatment 
of attention-deficit/hyperactivity disorder in children and adolescents. Council on 
Scientific Affairs, American Medical Association. The Journal of the American 
Medical Association, 279, 1100-1107. 
Gollwitzer, P. M. (1993). Goal achievement: The role of intentions. European Review of 
Social Psychology, 4, 141-185. 
Gollwitzer, P. M. (1999). Implementation intentions: Strong effects of simple plans. 
American Psychologist, 54, 493-503. 
Gollwitzer, P. M., & Sheeran, P. (2006). Implementation intentions and goal achievement: 
A meta‐analysis of effects and processes. In P. Z. Mark (Ed.), Advances in 
experimental social psychology (Vol. 38, pp. 69-119): Academic Press. 
Gomez, R., Harvey, J., Quick, C., Scharer, I., & Harris, G. (1999). DSM-IV AD/HD: 
confirmatory factor models, prevalence, and gender and age differences based on 
91 
parent and teacher ratings of Australian primary school children. Journal of Child 
Psychology and Psychiatry, 40, 265-274. 
Greve, K. W., Stickle, T. R., Love, J. M., Bianchini, K. J., & Stanford, M. S. (2005). Latent 
structure of the Wisconsin Card Sorting Test: a confirmatory factor analytic study. 
Archives of Clinical Neuropsychology, 20, 355-364. 
Groom, M. J., Bates, A. T., Jackson, G. M., Calton, T. G., Liddle, P. F., & Hollis, C. (2008). 
Event-related potentials in adolescents with schizophrenia and their siblings: a 
comparison with attention-deficit/hyperactivity disorder. Biological Psychiatry, 63, 
784-792. 
Groom, M. J., Cahill, J. D., Bates, A. T., Jackson, G. M., Calton, T. G., Liddle, P. F., & 
Hollis, C. (2010). Electrophysiological indices of abnormal error-processing in 
adolescents with attention deficit hyperactivity disorder (ADHD). Journal of Child 
Psychology and Psychiatry, 51, 66-76. 
Groom, M. J., Scerif, G., Liddle, P. F., Batty, M. J., Liddle, E. B., Roberts, K. L., . . . Hollis, 
C. (2010). Effects of motivation and medication on electrophysiological markers of 
response inhibition in children with attention-deficit/hyperactivity disorder. 
Biological Psychiatry, 67, 624-631. 
Grund, T., Lehmann, K., Bock, N., Rothenberger, A., & Teuchert-Noodt, G. (2006). 
Influence of methylphenidate on brain development--an update of recent animal 
experiments. Behavioral and Brain Functions, 2, 2. 
Guderjahn, L., Gold, A., Stadler, G., & Gawrilow, C. (2013). Self-regulation strategies 
support children with ADHD to overcome symptom-related behavior in the 
classroom. Attention Deficit and Hyperactivity Disorders, 5, 397-407. 
McGough, J., McCracken, J., Swanson, J., Riddle, M., Kollins, S., Greenhill, L., . . . Vitiello, 
B. (2006). Pharmacogenetics of methylphenidate response in preschoolers with 
92 
ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 
1314-1322. 
Halperin, J. M., Newcorn, J. H., Kopstein, I., McKay, K. E., Schwartz, S. T., Siever, L. J., 
& Sharma, V. (1997). Serotonin, aggression, and parental psychopathology in 
children with attention-deficit hyperactivity disorder. Journal of the American 
Academy of Child and Adolescent Psychiatry, 36, 1391-1398. 
Hammond, S. I., Müller, U., Carpendale, J. I. M., Bibok, M. B., & Liebermann-Finestone, 
D. P. (2012). The effects of parental scaffolding on preschoolers' executive function. 
Developmental Psychology, 48, 271-281. 
Hanwella, R., Senanayake, M., & de Silva, V. (2011). Comparative efficacy and 
acceptability of methylphenidate and atomoxetine in treatment of attention deficit 
hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry, 
11, 176. 
Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013). Meta-analysis of 
functional magnetic resonance imaging studies of inhibition and attention in 
attention-deficit/hyperactivity disorder: Exploring task-specific, stimulant 
medication, and age effects. JAMA Psychiatry, 70, 185-198. 
Hazell, P. L., Kohn, M. R., Dickson, R., Walton, R. J., Granger, R. E., & van Wyk, G. W. 
(2011). Core ADHD symptom improvement with atomoxetine versus 
methylphenidate: A direct comparison meta-analysis. Journal of Attention Disorders, 
15, 674-683. 
Heaton, S. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin 
card sorting test manual: Revised and expanded. Odessa, FL: Psychological 
Assessment Resources. 
93 
Heiser, P., Frey, J., Smidt, J., Sommerlad, C., Wehmeier, P. M., Hebebrand, J., & 
Remschmidt, H. (2004). Objective measurement of hyperactivity, impulsivity, and 
inattention in children with hyperkinetic disorders before and after treatment with 
methylphenidate. European Child and Adolescent Psychiatry, 13, 100-104. 
Herrmann, M. J., Mader, K., Schreppel, T., Jacob, C., Heine, M., Boreatti-Hummer, A., . . . 
Fallgatter, A. J. (2010). Neural correlates of performance monitoring in adult 
patients with attention deficit hyperactivity disorder (ADHD). The World Journal of 
Biological Psychiatry, 11, 457-464. 
Hinshaw, S. P., & Arnold, L. E. (2015). ADHD, multimodal treatment, and longitudinal 
outcome: evidence, paradox, and challenge. Wiley Interdisciplinary Reviews: 
Cognitive Science, 6, 39-52. 
Hsieh, M.-F. (2004). Teaching practices in Taiwan's education for young children: 
complexity and ambiguity of developmentally appropriate practices and/or 
developmentally inappropriate practices. Contemporary Issues in Early Childhood, 
5, 309-329. 
Huizenga, H. M., van Bers, B. M., Plat, J., van den Wildenberg, W. P., & van der Molen, M. 
W. (2009). Task complexity enhances response inhibition deficits in childhood and 
adolescent attention-deficit/hyperactivity disorder: a meta-regression analysis. 
Biological Psychiatry, 65, 39-45. 
Huss, M., Hölling, H., Schlack, R., & Kurth, B. M. (2008). How often are German children 
and adolescents diagnosed with ADHD? Prevalence based on the judgement of 
health care professionals: results of the German health and examination survey 
(KiGGS). European Child and Adolescent Psychiatry, 17, 52-58.  
94 
Itagaki, S., Yabe, H., Mori, Y., Ishikawa, H., Takanashi, Y., & Niwa, S. (2011). Event-
related potentials in patients with adult attention-deficit/hyperactivity disorder 
versus schizophrenia. Psychiatry Research, 189, 288-291. 
Jaušovec, N., & Jaušovec, K. (2000). Correlations between ERP parameters and intelligence: 
a reconsideration. Biological Psychology, 55, 137-154. 
Jensen, P. S. (2009). Review: methylphenidate and psychosocial treatments either alone or 
in combination reduce ADHD symptoms. Evidence Based Mental Health, 12, 18. 
Jodo, E., & Kayama, Y. (1992). Relation of a negative component to response inhibition in 
a Go/No-Go task. Electroencephalography and Clinical Neurophysiology, 82, 477-
482. 
Johnstone, S. J., Barry, R. J., & Clarke, A. R. (2013). Ten years on: A follow-up review of 
ERP research in attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 
124, 644-657. 
Johnstone, S. J., Barry, R. J., Markovska, V., Dimoska, A., & Clarke, A. R. (2009). 
Response inhibition and interference control in children with AD/HD: a visual ERP 
investigation. International Journal of Psychophysiology, 72, 145-153. 
Johnstone, S. J., Dimoska, A., Smith, J. L., Barry, R. J., Pleffer, C. B., Chiswick, D., & 
Clarke, A. R. (2007). The development of stop-signal and Go/Nogo response 
inhibition in children aged 7-12 years: performance and event-related potential 
indices. International Journal of Psychophysiology, 63, 25-38. 
Johnstone, S. J., Pleffer, C. B., Barry, R. J., Clarke, A. R., & Smith, J. L. (2005). 
Development of inhibitory processing during the Go/NoGo task: A behavioral and 
event-related potential study of children and adults. Journal of Psychophysiology, 19, 
11-23. 
95 
Jonkman, L. M., Kemner, C., Verbaten, M. N., Koelega, H. S., Camfferman, G., v.d. Gaag, 
R.-J., . . . van Engeland, H. (1997). Event-related potentials and performance of 
attention-deficit hyperactivity disorder: Children and normal controls in auditory and 
visual selective attention tasks. Biological Psychiatry, 41, 595-611. 
Jonkman, L. M., Lansbergen, M., & Stauder, J. E. (2003). Developmental differences in 
behavioral and event-related brain responses associated with response preparation 
and inhibition in a go/nogo task. Psychophysiology, 40, 752-761. 
Keller, H. (2007). Cultures of infancy. Mahwah, NJ: Erlbaum. 
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., . . . 
Allen, A. J. (2004). Once-daily atomoxetine treatment for children with attention-
deficit/hyperactivity disorder, including an assessment of evening and morning 
behavior: a double-blind, placebo-controlled trial. Pediatrics, 114, e1-8. 
Klorman, R. (1991). Cognitive event-related potentials in attention deficit disorder. Journal 
of Learning Disabilities, 24, 130-140. 
Kok, A. (2001). On the utility of P3 amplitude as a measure of processing capacity. 
Psychophysiology, 38, 557-577. 
Konrad, K., Neufang, S., Fink, G. R., & Herpertz-Dahlmann, B. (2007). Long-term effects 
of methylphenidate on neural networks associated with executive attention in 
children with ADHD: results from a longitudinal functional MRI study. Journal of 
the American Academy of Child and Adolescent Psychiatry, 46, 1633-1641. 
Kutas, M., McCarthy, G., & Donchin, E. (1977). Augmenting mental chronometry: the 
P300 as a measure of stimulus evaluation time. Science, 197, 792-795. 
Lansford, J. E., Chang, L., Dodge, K. A., Malone, P. S., Oburu, P., Palmerus, K. . . . Quinn, 
N. (2005). Physical discipline and children's adjustment: cultural normativeness as a 
moderator. Child Development, 76, 1234-1246. 
96 
Levy, F., Hay, D. A., Bennett, K. S., & McStephen, M. (2005). Gender differences in 
ADHD subtype comorbidity. Journal of the American Academy of Child and 
Adolescent Psychiatry, 44, 368-376. 
Li, D., Sham, P. C., Owen, M. J., & He, L. (2006). Meta-analysis shows significant 
association between dopamine system genes and attention deficit hyperactivity 
disorder (ADHD). Human Molecular Genetics, 15, 2276-2284. 
Lijffijt, M., Kenemans, J. L., Verbaten, M. N., & van Engeland, H. (2005). A meta-analytic 
review of stopping performance in attention-deficit/hyperactivity disorder: deficient 
inhibitory motor control? Journal of Abnormal Psychology, 114, 216-222. 
Liotti, M., Pliszka, S. R., Higgins, K., Perez, R. 3rd, & Semrud-Clikeman, M. (2010). 
Evidence for specificity of ERP abnormalities during response inhibition in ADHD 
children: a comparison with reading disorder children without ADHD. Brain and 
Cognition, 72, 228-237. 
Liotti, M., Pliszka, S. R., Perez, R. 3rd, Luus, B., Glahn, D., & Semrud-Clikeman, M. 
(2007). Electrophysiological correlates of response inhibition in children and 
adolescents with ADHD: influence of gender, age, and previous treatment history. 
Psychophysiology, 44, 936-948. 
Liotti, M., Pliszka, S. R., Perez, R., Kothmann, D., & Woldorff, M. G. (2005). Abnormal 
brain activity related to performance monitoring and error detection in children with 
ADHD. Cortex, 41, 377-388. 
Liu, Y. C., Liu, S. K., Shang, C. Y., Lin, C. H., Tu, C. L., & Gau, S. S. F. (2006). Norm, 
reliability, and validity of the Chinese version of the Swanson, Nolan and Pelham, 
Version IV Scale. Taiwanese Journal of Psychiatry, 20, 290-304. 
97 
Logan, G. D., Cowan, W. B., & Davis, K. A. (1984). On the ability to inhibit simple and 
choice reaction time responses: a model and a method. Journal of Experimental 
Psychology: Human Perception and Performance, 10, 276-291. 
Logan, G. D., Schachar, R. J., & Tannock, R. (1997). Impulsivity and inhibitory control. 
Psychological Science, 8, 60-64. 
Luck, S. J. (2005). An introduction to the event-related potential technique. Cambridge, 
Mass: MIT Press. 
MacLaren, V. V., Taukulis, H. K., & Best, L. A. (2007). Inhibition in adults with attention 
deficit/hyperactivity disorder: event-related potentials in the stop task. Applied 
Psychophysiology and Biofeedback, 32, 155-162. 
Mann, E. M., Ikeda, Y., Mueller, C. W., Takahashi, A., Tao, K. T., Humris, E., . . . Chin, D. 
(1992). Cross-cultural differences in rating hyperactive-disruptive behaviors in 
children. The American Journal of Psychiatry, 149, 1539-1542. 
Martenyi, F., Zavadenko, N. N., Jarkova, N. B., Yarosh, A. A., Soldatenkova, V. O., 
Bardenstein, L. M., . . . Zykov, V. P. (2010). Atomoxetine in children and 
adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, 
placebo-controlled, double-blind trial in Russia. European Child and Adolescent 
Psychiatry, 19, 57-66. 
Martin, W. E., & Bridgmon, K. D. (2012). Quantitative and statistical research methods: 
From hypothesis to results. Somerset, NJ: Wiley. 
Mash, E. J., & Wolfe, D. A. (2007). Abnormal child psychology (4th edition). Belmon, CA: 
Wadsworth. 
McLoughlin, G., Albrecht, B., Banaschewski, T., Rothenberger, A., Brandeis, D., Asherson, 
P., & Kuntsi, J. (2009). Performance monitoring is altered in adult ADHD: a familial 
event-related potential investigation. Neuropsychologia, 47, 3134-3142. 
98 
Metin, B., Roeyers, H., Wiersema, J. R., van der Meere, J., & Sonuga-Barke, E. (2012). A 
meta-analytic study of event rate effects on go/no-go performance in attention-
deficit/hyperactivity disorder. Biological Psychiatry, 72, 990-996. 
Meyer, A. (2005). Cross cultural issues in ADHD research. Journal of Psychology in Africa, 
10, 101-106. 
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., & Spencer, 
T. (2001). Atomoxetine in the treatment of children and adolescents with attention-
deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response 
study. Pediatrics, 108, E83. 
Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. (1996). Is maternal 
smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in 
children? The American Journal of Psychiatry, 153, 1138-1142. 
Milberger, S., Biederman, J., Faraone, S. V., Guite, J., & Tsuang, M. T. (1997). Pregnancy, 
delivery and infancy complications and attention deficit hyperactivity disorder: 
Issues of gene-environment interaction. Biological Psychiatry, 41, 65-75. 
Miller, M., Ho, J., & Hinshaw, S. P. (2012). Executive functions in girls with ADHD 
followed prospectively into young adulthood. Neuropsychology, 26, 278-287. 
Murphy, P. (2002). Inhibitory control in adults with attention-deficit/hyperactivity disorder. 
Journal of Attention Disorders, 6, 1-4. 
Nigg, J. T. (2001). Is ADHD a disinhibitory disorder? Psychological Bulletin, 127, 571-598. 
Nigg, J. T., Butler, K. M., Huang-Pollock, C. L., & Henderson, J. M. (2002). Inhibitory 
processes in adults with persistent childhood onset ADHD. Journal of Consulting 
and Clinical Psychology, 70, 153-157. 
99 
Nikolas, M. A., Klump, K. L., & Burt, S. A. (2015). Parental involvement moderates 
etiological influences on attention deficit hyperactivity disorder behaviors in child 
twins. Child Development, 86, 224-240. 
Nordstokke, D. W., & Zumbo, B. D. (2010). A new nonparametric Levene test for equal 
variances. Psicologica, 31, 401-430. 
Nordstokke, D. W., Zumbo, B. D., Cairns, S. L., & Saklofske, D. H. (2011). The operating 
characteristics of the nonparametric Levene test for equal variances with assessment 
and evaluation data. Practical Assessment, Research and Evaluation, 1. 
O'Connell, R. G., Bellgrove, M. A., Dockree, P. M., Lau, A., Hester, R., Garavan, H., . . . 
Robertson, I. H. (2009). The neural correlates of deficient error awareness in 
attention-deficit hyperactivity disorder (ADHD). Neuropsychologia, 47, 1149-1159. 
O'Donnell, B. F., Friedman, S., Swearer, J. M., & Drachman, D. A. (1992). Active and 
passive P3 latency and psychometric performance: influence of age and individual 
differences. International Journal of Psychophysiology, 12, 187-195. 
Oettingen, G., Sevincer, A. T., & Gollwitzer, P. M. (2008). Goal pursuit in the context of 
culture. In R. Sorrentino & S. Yamaguchi (Eds.), The handbook of motivation and 
cognition across cultures (pp. 191-211). San Diego: Elsevier/Academic Press. 
Olson, S., Tardif, T., Miller, A., Felt, B., Grabell, A., Kessler, D., . . . Hirabayashi, H. 
(2011). Inhibitory control and harsh discipline as predictors of externalizing 
problems in young children: a comparative study of U.S., Chinese, and Japanese 
preschoolers. Journal of Abnormal Child Psychology, 39, 1163-1175. 
Oosterlaan, J., Logan, G. D., & Sergeant, J. A. (1998). Response inhibition in AD/HD, CD, 
comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies 
with the stop task. Journal of Child Psychology and Psychiatry, 39, 411-425. 
100 
Oosterlaan, J., & Sergeant, J. A. (1996). Inhibition in ADHD, aggressive, and anxious 
children: a biologically based model of child psychopathology. Journal of Abnormal 
Child Psychology, 24, 19-36. 
Ossmann, J. M., & Mulligan, N. W. (2003). Inhibition and attention deficit hyperactivity 
disorder in adults. The American Journal of Psychology, 116, 35-50. 
Overtoom, C. C., Kenemans, J. L., Verbaten, M. N., Kemner, C., van der Molen, M. W., 
van Engeland, H., . . . Koelega, H. S. (2002). Inhibition in children with attention-
deficit/hyperactivity disorder: a psychophysiological study of the stop task. 
Biological Psychiatry, 51, 668-676. 
Overtoom, C. C., Verbaten, M. N., Kemner, C., Kenemans, J. L., van Engeland, H., 
Buitelaar, J. K., . . . Koelega, H. S. (1998). Associations between event-related 
potentials and measures of attention and inhibition in the Continuous Performance 
Task in children with ADHD and normal controls. Journal of the American 
Academy of Child and Adolescent Psychiatry, 37, 977-985. 
Paul-Jordanov, I., Bechtold, M., & Gawrilow, C. (2010). Methylphenidate and if-then plans 
are comparable in modulating the P300 and increasing response inhibition in 
children with ADHD. Attention Deficit and Hyperactivity Disorders, 2, 115-126. 
Paul, I., Gawrilow, C., Zech, F., Gollwitzer, P., Rockstroh, B., Odenthal, G., . . . Wienbruch, 
C. (2007). If-then planning modulates the P300 in children with attention deficit 
hyperactivity disorder. Neuroreport, 18, 653-657. 
Pauls, A. M., O'Daly, O. G., Rubia, K., Riedel, W. J., Williams, S. C., & Mehta, M. A. 
(2012). Methylphenidate effects on prefrontal functioning during attentional-capture 
and response inhibition. Biological Psychiatry, 72, 142-149. 
Pelosi, L., Holly, M., Slade, T., Hayward, M., Barrett, G., & Blumhardt, L. D. (1992). 
Event-related potential (ERP) correlates of performance of intelligence tests. 
101 
Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section, 
84, 515-520. 
Pennington, B. F., & Ozonoff, S. (1996). Executive functions and developmental 
psychopathology. Journal of Child Psychology and Psychiatry, 37, 51-87. 
Picton, T. W. (1992). The P300 wave of the human event-related potential. Journal of 
Clinical Neurophysiology, 9, 456-479. 
Pliszka, S. R. (1998). Comorbidity of attention-deficit/hyperactivity disorder with 
psychiatric disorder: An overview. Journal of Clinical Psychiatry, 59, 50-58. 
Pliszka, S. R. (2009). Treating ADHD and comorbid disorders. New York, NY: The 
Guilford Press. 
Pliszka, S. R., Borcherding, S. H., Spratley, K., Leon, S., & Irick, S. (1997). Measuring 
inhibitory control in children. Journal of Developmental and Behavioral Pediatrics, 
18, 254-259. 
Pliszka, S. R., Glahn, D., Semrud-Clikeman, M., Franklin, C., Perez, R. 3rd, Xiong, J., & 
Liotti, M. (2006). Neuroimaging of inhibitory control areas in children with 
attention deficit hyperactivity disorder who were treatment naive or in long-term 
treatment. The American Journal of Psychiatry, 163, 1052-1060. 
Pliszka, S. R., Liotti, M., Bailey, B. Y., Perez, R. 3rd, Glahn, D., & Semrud-Clikeman, M. 
(2007). Electrophysiological effects of stimulant treatment on inhibitory control in 
children with attention-deficit/hyperactivity disorder. Journal of Child and 
Adolescent Psychopharmacology, 17, 356-366. 
Pliszka, S. R., Liotti, M., & Woldorff, M. G. (2000). Inhibitory control in children with 
attention-deficit/hyperactivity disorder: event-related potentials identify the 
processing component and timing of an impaired right-frontal response-inhibition 
mechanism. Biological Psychiatry, 48, 238-246. 
102 
Pliszka, S. R., McCracken, J. T., & Maas, J. W. (1996). Catecholamines in attention-deficit 
hyperactivity disorder: current perspectives. Journal of the American Academy of 
Child and Adolescent Psychiatry, 35, 264-272. 
Polanczyk, G., de Lima, M., Horta, B., Biederman, J., & Rohde, L. (2007). The worldwide 
prevalence of ADHD: a systematic review and metaregression analysis. The 
American Journal of Psychiatry, 164, 942-948. 
Polich, J., Howard, L., & Starr, A. (1983). P300 latency correlates with digit span. 
Psychophysiology, 20, 665-669. 
Prox, V., Dietrich, D. E., Zhang, Y., Emrich, H. M., & Ohlmeier, M. D. (2007). Attentional 
processing in adults with ADHD as reflected by event-related potentials. 
Neuroscience Letters, 419, 236-241. 
Quay, H. C. (1997). Inhibition and attention deficit hyperactivity disorder. Journal of 
Abnormal Child Psychology, 25, 7-13. 
Razali, N. M., & Wah, Y. B. (2011). Power comparisons of Shapiro-Wilk, Kolmogorov-
Smirnov, Lilliefors and Anderson-Darling tests. Journal of Statistical Modeling and 
Analytics, 2, 21-33. 
Reid, R., Trout, A. L., & Schartz, M. (2005). Self-regulation interventions for children with 
attention deficit/hyperactivity disorder. Exceptional Children, 71, 361-377. 
Rodrigo, A. H., Domenico, S. I. D., Ayaz, H., Gulrajani, S., Lam, J., & Ruocco, A. C. 
(2014). Differentiating functions of the lateral and medial prefrontal cortex in motor 
response inhibition. Neuroimage, 85, Part 1, 423-431. 
Rodriguez, P. D., & Baylis, G. C. (2007). Activation of brain attention systems in 
individuals with symptoms of ADHD. Behavioural Neurology, 18, 115-130. 
103 
Rubia, K., Alegria, A. A., Cubillo, A. I., Smith, A. B., Brammer, M. J., & Radua, J. (2014). 
Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a 
systematic review and meta-analysis. Biological Psychiatry, 76, 616-628. 
Rubia, K., Cubillo, A., Smith, A. B., Woolley, J., Heyman, I., & Brammer, M. J. (2010). 
Disorder-specific dysfunction in right inferior prefrontal cortex during two inhibition 
tasks in boys with attention-deficit hyperactivity disorder compared to boys with 
obsessive–compulsive disorder. Human Brain Mapping, 31, 287-299. 
Rubia, K., Oosterlaan, J., Sergeant, J. A., Brandeis, D., & v. Leeuwen, T. (1998). Inhibitory 
dysfunction in hyperactive boys. Behavioural Brain Research, 94, 25-32. 
Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C., Simmons, A., & 
Bullmore, E. T. (1999). Hypofrontality in attention deficit hyperactivity disorder 
during higher-order motor control: a study with functional MRI. The American 
Journal of Psychiatry, 156, 891-896. 
Rubia, K., Russell, T., Overmeyer, S., Brammer, M. J., Bullmore, E. T., Sharma, T., . . . 
Taylor, E. (2001). Mapping motor inhibition: conjunctive brain activations across 
different versions of go/no-go and stop tasks. Neuroimage, 13, 250-261. 
Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003). Right inferior prefrontal 
cortex mediates response inhibition while mesial prefrontal cortex is responsible for 
error detection. Neuroimage, 20, 351-358. 
Rubia, K., Smith, A. B., Brammer, M. J., Toone, B., & Taylor, E. (2005). Abnormal brain 
activation during inhibition and error detection in medication-naive adolescents with 
ADHD. The American Journal of Psychiatry, 162, 1067-1075. 
Sawaki, R., & Katayama, J. (2006). Severity of AD/HD symptoms and efficiency of 
attentional resource allocation. Neuroscience Letters, 407, 86-90. 
104 
Scahill, L., Carroll, D., & Burke, K. (2004). Methylphenidate: Mechanism of action and 
clinical update. Journal of Child and Adolescent Psychiatric Nursing, 17, 85-86. 
Schachter, H. M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious 
and safe is short-acting methylphenidate for the treatment of attention-deficit 
disorder in children and adolescents? A meta-analysis. Canadian Medical 
Association Journal, 165, 1475–1488. 
Schachar, R., Logan, G. D., Robaey, P., Chen, S., Ickowicz, A., & Barr, C. (2007). Restraint 
and cancellation: multiple inhibition deficits in attention deficit hyperactivity 
disorder. Journal of Abnormal Child Psychology, 35, 229-238. 
Schneider, M., Retz, W., Freitag, C., Irsch, J., Graf, P., Retz-Junginger, P., & Rosler, M. 
(2007). Impaired cortical inhibition in adult ADHD patients: a study with 
transcranial magnetic stimulation. Journal of Neural Transmission Supplement, 303-
309. 
Schubert, I., Selke, G. I., Osswald-Huang, P. H., Schroeder, H., & Nink, K. (2002). 
Methylphenidat-Verordnungsanalyse auf der Basis von GKV-Daten. Bonn: 
Wissenschaftliches Institut der AOK. 
Schulz, K. P., Fan, J., Tang, C. Y., Newcorn, J. H., Buchsbaum, M. S., Cheung, A. M., & 
Halperin, J. M. (2004). Response inhibition in adolescents diagnosed with attention 
deficit hyperactivity disorder during childhood: an event-related FMRI study. The 
American Journal of Psychiatry, 161, 1650-1657. 
Seifert, J., Scheuerpflug, P., Zillessen, K. E., Fallgatter, A., & Warnke, A. (2003). 
Electrophysiological investigation of the effectiveness of methylphenidate in 
children with and without ADHD. Journal of Neural Transmission, 110, 821-829. 
105 
Seipp, C., & Johnston, C. (2005). Mother–son interactions in families of boys with 
attention-deficit/hyperactivity disorder with and without oppositional behavior. 
Journal of Abnormal Child Psychology, 33, 87-98. 
Senderecka, M., Grabowska, A., Szewczyk, J., Gerc, K., & Chmylak, R. (2012). Response 
inhibition of children with ADHD in the stop-signal task: an event-related potential 
study. International Journal of Psychophysiology, 85, 93-105. 
Shang, C.-Y., Gau, S. S.-F., Liu, C.-M., & Hwu, H.-G. (2011). Association between the 
dopamine transporter gene and the inattentive subtype of attention deficit 
hyperactivity disorder in Taiwan. Progress in Neuro-Psychopharmacology and 
Biological Psychiatry, 35, 421-428. 
Shang, C. Y., Wu, Y. H., Gau, S. S., & Tseng, W. Y. (2013). Disturbed microstructural 
integrity of the frontostriatal fiber pathways and executive dysfunction in children 
with attention deficit hyperactivity disorder. Psychological Medicine, 43, 1093-1107. 
Shapiro, S. S., & Wilk, M. B. (1965). An Analysis of Variance Test for Normality 
(Complete Sample). Biometrika, 52, 591-611. 
Sheeran, P., Webb, T. L., & Gollwitzer, P. M. (2006). Implementation intentions: Strategic 
automatisation of goal striving. In D. T. M. de Ridder & J. B. F. de Wit (Eds.), Self-
regulation in health behavior (pp. 121-145). London: John Wiley & Sons Ltd. 
Shen, I. H., Tsai, S. Y., & Duann, J. R. (2011). Inhibition control and error processing in 
children with attention deficit/hyperactivity disorder: an event-related potentials 
study. International Journal of Psychophysiology, 81, 1-11. 
Smalley, S. L., McGough, J. J., Moilanen, I. K., Loo, S. K., Taanila, A., Ebeling, H., . . . 
JÄRvelin, M.-R. (2007). Prevalence and psychiatric comorbidity of attention-
deficit/hyperactivity disorder in an adolescent Finnish population. Journal of the 
American Academy of Child and Adolescent Psychiatry, 46, 1575-1583. 
106 
Smith, A., Taylor, E., Brammer, M., Toone, B., & Rubia, K. (2006). Task-specific 
hypoactivation in prefrontal and temporoparietal brain regions during motor 
inhibition and task switching in medication-naive children and adolescents with 
attention deficit hyperactivity disorder. The American Journal of Psychiatry, 163, 
1044-1051. 
Smith, J. L., Johnstone, S. J., & Barry, R. J. (2004). Inhibitory processing during the 
Go/NoGo task: an ERP analysis of children with attention-deficit/hyperactivity 
disorder. Clinical Neurophysiology, 115, 1320-1331. 
Sonuga-Barke, E. J. (2002). Psychological heterogeneity in AD/HD--a dual pathway model 
of behaviour and cognition. Behavioural Brain Research, 130, 29-36. 
Sonuga-Barke, E. J., Taylor, E., Sembi, S., & Smith, J. (1992). Hyperactivity and delay 
aversion--I. The effect of delay on choice. Journal of Child Psychology and 
Psychiatry, 33, 387-398. 
Sonuga-Barke, E. J., Williams, E., Hall, M., & Saxton, T. (1996). Hyperactivity and delay 
aversion. III: The effect on cognitive style of imposing delay after errors. Journal of 
Child Psychology and Psychiatry, 37, 189-194. 
Spencer, T. J. (2006). ADHD and comorbidity in childhood. Journal of Clinical Psychiatry, 
67, 27-31. 
Strandburg, R. J., Marsh, J. T., Brown, W. S., Asarnow, R. F., Higa, J., Harper, R., & 
Guthrie, D. (1996). Continuous-processing-related event-related potentials in 
children with attention deficit hyperactivity disorder. Biological Psychiatry, 40, 964-
980. 
Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. 
B., . . . Wu, M. (2001). Clinical relevance of the primary findings of the MTA: 
success rates based on severity of ADHD and ODD symptoms at the end of 
107 
treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 
168-179. 
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & 
Cantwell, D. P. (1998). Attention-deficit hyperactivity disorder and hyperkinetic 
disorder. The Lancet, 351, 429-433. 
Tannock, R., Schachar, R. J., Carr, R. P., Chajczyk, D., & Logan, G. D. (1989). Effects of 
methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal 
Child Psychology, 17, 473-491. 
Tannock, R., Schachar, R. J., Carr, R. P., & Logan, G. D. (1989). Dose-response effects of 
methylphenidate on academic performance and overt behavior in hyperactive 
children. Pediatrics, 84, 648-657. 
Tekok-Kilic, A., Shucard, J. L., & Shucard, D. W. (2001). Stimulus modality and Go/NoGo 
effects on P3 during parallel visual and auditory continuous performance tasks. 
Psychophysiology, 38, 578-589. 
Thapar, A., Fowler, T., Rice, F., Scourfield, J., van den Bree, M., Thomas, H., . . . Hay, D. 
(2003). Maternal smoking during pregnancy and attention deficit hyperactivity 
disorder symptoms in offspring. The American Journal of Psychiatry, 160, 1985-
1989. 
The MTA Cooperative Group. (1999a). A 14-month randomized clinical trial of treatment 
strategies for attention-deficit/hyperactivity disorder. The MTA cooperative group. 
Multimodal treatment study of children with ADHD. Archives of General Psychiatry, 
56, 1073-1086. 
The MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for 
children with attention-deficit/hyperactivity disorder: the multimodal treatment 
108 
study of children with attention-deficit/hyperactivity disorder. Archives of General 
Psychiatry, 56, 1088-1096. 
Thorell, L. B., Veleiro, A., Siu, A. F., & Mohammadi, H. (2013). Examining the relation 
between ratings of executive functioning and academic achievement: findings from 
a cross-cultural study. Child Neuropsychology, 19, 630-638. 
Trommsdorff, G., Cole, P. M., & Heikamp, T. (2012). Cultural variations in mothers' 
intuitive theories: a preliminary report on interviewing mothers from five nations 
about their socialization of children's emotions. Global Studies of Childhood, 2, 158-
169. 
Trommsdorff, G., & Kornadt, H.-J. (2003). Parent-child relations in cross-cultural 
perspective. In L. Kuczynski (Ed.), Handbook of dynamics in parent-child relations 
(pp. 271-306). London: Sage. 
Tzang, R. F., Wang, Y. C., Yeh, C. B., Hsu, C. D., Liang, H. Y., Yang, P. C., . . . Chang, H. 
L. (2012). Naturalistic exploration of the effect of osmotic release oral system-
methylphenidate on remission rate and functional improvement in Taiwanese 
children with attention-deficit-hyperactivity disorder. Psychiatry and Clinical 
Neurosciences, 66, 53-63. 
Uebel, H., Albrecht, B., Asherson, P., Börger, N. A., Butler, L., Chen, W., . . . 
Banaschewski, T. (2010). Performance variability, impulsivity errors and the impact 
of incentives as gender-independent endophenotypes for ADHD. Journal of Child 
Psychology and Psychiatry, 51, 210-218. 
Valko, L., Doehnert, M., Müller, U. C., Schneider, G., Albrecht, B., Drechsler, R., . . . 
Brandeis, D. (2009). Differences in neurophysiological markers of inhibitory and 
temporal processing deficits in children and adults with ADHD. Journal of 
Psychophysiology, 23, 235-246. 
109 
Van der Oord, S., Prins, P. J. M., Oosterlaan, J., & Emmelkamp, P. M. G. (2008). Efficacy 
of methylphenidate, psychosocial treatments and their combination in school-aged 
children with ADHD: A meta-analysis. Clinical Psychology Review, 28, 783-800. 
van der Stelt, O., Frye, J., Lieberman, J. A., & Belger, A. (2004). Impaired P3 generation 
reflects high-level and progressive neurocognitivedysfunction in schizophrenia. 
Archives of General Psychiatry, 61, 237-248. 
Verbruggen, F., Chambers, C. D., & Logan, G. D. (2013). Fictitious inhibitory differences: 
How skewness and slowing distort the estimation of stopping latencies. 
Psychological Science, 24, 352-362. 
Walhovd, K. B., & Fjell, A. M. (2002). The relationship between P3 and 
neuropsychological function in an adult life span sample. Biological Psychology, 62, 
65-87. 
Wanless, S. B., McClelland, M. M., Acock, A. C., Ponitz, C. C., Son, S.-H., Lan, X., . . . Li, 
S. (2011). Measuring behavioral regulation in four societies. Psychological 
Assessment, 23, 364-378. 
Webb, T. L., & Sheeran, P. (2006). Does changing behavioral intentions engender behavior 
change? A meta-analysis of the experimental evidence. Psychological Bulletin, 132, 
249-268. 
Webb, T. L., & Sheeran, P. (2008). Mechanisms of implementation intention effects: the 
role of goal intentions, self-efficacy, and accessibility of plan components. The 
British Journal of Social Psychology, 47, 373-395. 
Wehmeier, P. M., Schacht, A., Ulberstad, F., Lehmann, M., Schneider-Fresenius, C., 
Lehmkuhl, G., . . . Banaschewski, T. (2012). Does atomoxetine improve executive 
function, inhibitory control, and hyperactivity?: Results from a placebo-controlled 
110 
trial using quantitative measurement technology. Journal of Clinical 
Psychopharmacology, 32, 653-660. 
Welsh, M. C., & Pennington, B. F. (1988). Assessing frontal lobe functioning in children: 
Views from developmental psychology. Developmental Neuropsychology, 4, 199-
230. 
Wiersema, J. R., van der Meere, J., Antrop, I., & Roeyers, H. (2006). State regulation in 
adult ADHD: an event-related potential study. Journal of Clinical and Experimental 
Neuropsychology, 28, 1113-1126. 
Wiersema, J. R., van der Meere, J. J., & Roeyers, H. (2005). ERP correlates of impaired 
error monitoring in children with ADHD. Journal of Neural Transmission, 112, 
1417-1430. 
Wiersema, J. R., van der Meere, J. J., & Roeyers, H. (2009). ERP correlates of error 
monitoring in adult ADHD. Journal of Neural Transmission, 116, 371-379. 
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005). 
Validity of the executive function theory of attention-deficit/hyperactivity disorder: 
A meta-analytic review. Biological Psychiatry, 57, 1336-1346. 
Williams, B. R., Ponesse, J. S., Schachar, R. J., Logan, G. D., & Tannock, R. (1999). 
Development of inhibitory control across the life span. Developmental Psychology, 
35, 205-213. 
Wodushek, T. R., & Neumann, C. S. (2003). Inhibitory capacity in adults with symptoms of 
attention deficit/hyperactivity disorder (ADHD). Archives of Clinical 
Neuropsychology, 18, 317-330. 
Wolf, R. C., Plichta, M. M., Sambataro, F., Fallgatter, A. J., Jacob, C., Lesch, K.-P., . . . 
Vasic, N. (2009). Regional brain activation changes and abnormal functional 
connectivity of the ventrolateral prefrontal cortex during working memory 
111 
processing in adults with attention-deficit/hyperactivity disorder. Human Brain 
Mapping, 30, 2252-2266. 
Woodward, L., Taylor, E., & Dowdney, L. (1998). The parenting and family functioning of 
children with hyperactivity. Journal of Child Psychology and Psychiatry, 39, 161-
169. 
World Health Organization. (2008). ICD-10: International statistical classification of 
diseases and related health problems (10th Rev. ed.). New York, NY: World Health 
Organization. 
Yang, H. J., Chen, W. J., & Soong, W. T. (2001). Rates and patterns of comorbidity of 
adolescent behavioral syndromes as reported by parents and teachers in a Taiwanese 
nonreferred sample. Journal of the American Academy of Child and Adolescent 
Psychiatry, 40, 1045-1052. 
Yang, H. J., Soong, W. T., Chiang, C. N., & Chen, W. J. (2000). Competence and 
behavioral/emotional problems among Taiwanese adolescents as reported by parents 
and teachers. Journal of the American Academy of Child and Adolescent Psychiatry, 
39, 232-239. 
Zhang, J. S., Wang, Y., Cai, R. G., & Yan, C. H. (2009). The brain regulation mechanism of 
error monitoring in impulsive children with ADHD--an analysis of error related 
potentials. Neuroscience Letters, 460, 11-15. 
Zuvekas, S. H., Vitiello, B., & Norquist, G. S. (2006). Recent trends in stimulant 
medication use among U.S. children. The American Journal of Psychiatry, 163, 579-
585. 
  
112 
  
113 
慣用手問卷 
日期(西元年/月/日):  2013/ ___ ___/ ___ ___           ID: 
 
不同於一般調查問卷的方式，下列各個活動應該用手勢表達出來。施測者依序提出請求，然
後在左手/右手欄位打勾。請勾選出慣用手，也就是，哪一隻手握著/使用剪刀，筷子，掃帚
(在上端)，火柴，或是轉開瓶蓋? 當受測者不確定哪一隻手是慣用手時，也就是有時是用右手，
有時是用左手，那麼請在左手/右手兩個欄位都打勾 (或是再進一步詢問)。對於第八題，很多
受測者不是很確定，這時施測者可要求受測者在原地做出打掃的動作，來幫助他們。 
請你示範一次, 你如何... 左手 右手 
 1)   ... 寫字   
 2)          ... 畫圖   
 3)          ... 丟球   
 4)          ... 拿剪刀剪東西   
 5)     ... 刷牙   
 6)       ... 拿筷子夾東西   
 7)        ... 拿湯匙吃東西   
 8)        ... 用掃帚掃地   
 9)         ... 點火柴   
10)            ... 將瓶子上的瓶蓋轉開   
 
慣用手(註解:腦側化)商值( LQ)的計算是根據於勾選的左手/右手次數總和(正值為右手，負值
為左手)， 如下:  
       
   LQ = (R-L)/(R+L)x100   
 
他們用哪一隻手寫字? 
媽媽  (左) (右) (?) 姊妹  (左) (右) (?) 女兒 (左) (右) (?) 
爮爮 (左) (右) (?) 兄弟 (左) (右) (?) 兒子  (左) (右) (?) 
 
 
 
Oldfield, R. C. (1971). The assessment and analysis of handedness: The Edinburgh Inventory. 
 Neuropsychologia 9, 97-113. 
Annett, M. (1979). Family handedness in three generations predicted by the right shift 
theory. 
 Annals of Human Genetics 42, 479-491.  
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M-Check 電腦測驗(遊戲)問卷 
1. 你覺得專心在這個遊戲有多容易? 
1 2 3 4 5 6 7 
一點也不容易      非常容易 
2. 你有多專心在這個遊戲上? 
1 2 3 4 5 6 7 
一點也不專心      非常專心 
3. 你覺得這個遊戲會令人感到辛苦嗎? 
1 2 3 4 5 6 7 
一點也不辛苦       非常辛苦 
4. 你有多辛苦地玩這個遊戲? 
1 2 3 4 5 6 7 
一點也不辛苦      非常辛苦 
5 你有多好地完成總是按下正確按鍵的任務? 
1 2 3 4 5 6 7 
一點也不好      非常好 
6. 在手掌出現時，你有多好地完成總是不去按按鍵的任務? 
1 2 3 4 5 6 7 
一點也不好      非常好 
7. 你有為這個遊戲想到任何的策略嗎? 
沒有  有     
      如果有， 是什麼:   
姓名:                                
ID:                                 
日期/時間:               /  
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8. 你有多好地能將策略轉化為行動? 
1 2 3 4 5 6 7 
一點也不好      非常好 
9. 你有意圖刻意在手掌出現時不去按按鍵嗎? 
1 2 3 4 5 6 7 
沒有，一點也沒有      有， 非常 
10. 你有多好地能將這個意圖轉化為行動? 
1 2 3 4 5 6 7 
一點也不      非常好 
11. 在手掌出現時不要去按按鍵， 對你而言達成這個目標有多重要? 
1 2 3 4 5 6 7 
一點也不重要      非常重要 
12. 在手掌出現時不要去按按鍵， 對你而言達成這個目標有多辛苦? 
1 2 3 4 5 6 7 
一點也不辛苦      非常辛苦 
13. 在手掌出現時不要去按按鍵， 對你而言維持這個目標有多簡單? 
1 2 3 4 5 6 7 
一點也不簡單      非常簡單 
14. 在手掌出現時不要去按按鍵，你確信可以達到這個目標嗎? 
1 2 3 4 5 6 7 
不，一點也不      是的， 非常 
15. 你有認真地看待這個遊戲嗎? 
1 2 3 4 5 6 7 
不，一點也不      是的， 非常 
16. 你想要在這個遊戲表現特別地好嗎? 
1 2 3 4 5 6 7 
一點也不      非常好 
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17.你對於自己在遊戲中的表現感到自豪嗎? 
1 2 3 4 5 6 7 
一點也不      非常 
18.你參加這個遊戲， 只是因為可以得到獎金報酬嗎? 
1 2 3 4 5 6 7 
不是      是的 
19. 你想要比別人好嗎? 
1 2 3 4 5 6 7 
一點也不      非常 
20.你想要向施測者證明， 你表現得好嗎? 
1 2 3 4 5 6 7 
一點也不      非常 
21. 你認為你犯了多少錯誤呢? 
1 2 3 4 5 6 7 
一點也沒有      非常多 
22. 你有多確定， 你很好地完成這個任務了? 
1 2 3 4 5 6 7 
一點也不確信      非常確信 
23. 你想要在這個遊戲表現好嗎? 
1 2 3 4 5 6 7 
不，一點也不      是的，非常好 
請檢查是否有漏答的問題! 非常謝謝你的回答!  
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Task Instruction 
ID:   
日期/時間:  / 
  
施測者:   
組別: □ ADHD □ 控制組 
施測語: Control Instruction & Counterbalancing 1 
測驗:  □ 1 □ 2 
 
1. 指導語 階段一 
我們現在開始這個電腦遊戲。 它總共有四個階段。  
重要的是， 你應該試著盡可能安靜地坐著， 同時也不要亂動你的頭。 
在螢幕上看到交通工具 (汽車， 飛機， 火車頭， 船， 大貨車)， 你應該用右手按下藍色的鍵， 
看到動物(老鼠， 豬， 牛， 貓， 雞)， 用左手按下黃色的鍵。 
如同在每個電腦遊戲中， 要快速且正確，  
也就是說，你應該總是盡可能快速地按下正確的鍵。 
現在你就照著這樣做， 直到螢幕上出現鐘鈴。 然後， 我會再向你說明接下來要做什麼。 
2. 指導語 階段二 
現在你再做一次同樣的， 非常簡單地， 看到交通工具， 就用右手按下藍色的鍵，  
看到動物， 就用左手按下黃色的鍵。 
不同之前的是， 現在有時候在圖片之前會出現一隻手， 看到手的時候， 不論接下來的圖片
是什麼， 你都不應該再按鍵。 
3. 提問 
你可以向我簡短的說明， 現在你應該做什麼嗎?  
4. 指導語 
很好，現在你的任務是: 
看到交通工具按藍鍵， 看到動物按黃鍵， 在手後面出現的圖片， 不要按鍵。 
當鐘鈴在螢幕上出現時， 我們會有一個短暫的休息。 
然後我會再向你說明， 接下來要做什麼。 
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5. 指導語 階段三 
接下來的會較困難， 要交換按鍵。 
現在看到交通工具時， 用左手按下黃色的鍵。 看到動物時， 用右手按下藍色的鍵。 
現在你就照著這樣做， 直到螢幕上出現鐘鈴， 然後我會再向你說明， 接下來要做什麼。 
6. 指導語 階段四 
現在你再做一次同樣的， 非常簡單， 看到交通工具， 用左手按黃鍵， 看到動物， 用右手按
藍鍵。 
不同的是， 現在手會再次出現，看到手的時候， 不論接下來的圖片是什麼， 你都不應該再
按鍵。 
7. 問題 
你可以向我簡短的說明， 現在你應該做什麼嗎?  
8. 指導語 
很好，現在你的任務是: 
看到交通工具， 按黃鍵， 看到動物， 按藍鍵， 在手後面出現的圖片， 不要按鍵。 
當鐘鈴在螢幕上出現時， 這個遊戲就結束了。 
9. 結束 
在第一次的測驗之後，  
1. 感謝他/她的參與! 
 
在第二次的測驗之後，  
1. 詢問 M-Check  
2. 給受試者 500 元 
3. 感謝他/她的參與! 
 
  
121 
Task Instruction 
ID:   
日期/時間:  / 
  
施測者:   
組別: □ ADHD □ 控制組 
施測語: Control Instruction & Counterbalancing 2 
測驗:  □ 1 □ 2 
 
1. 指導語 階段一 
我們現在開始這個電腦遊戲。 它總共有四個階段。  
重要的是， 你應該試著盡可能安靜地坐著， 同時也不要亂動你的頭。 
在螢幕上看到交通工具 (汽車， 飛機， 火車頭， 船， 大貨車)， 你應該用左手按下黃色的鍵， 
看到動物(老鼠， 豬， 牛， 貓， 雞)， 用右手按下藍色的鍵。 
如同在每個電腦遊戲中， 要快速且正確，  
也就是說，你應該總是盡可能快速地按下正確的鍵。 
現在你就照著這樣做， 直到螢幕上出現鐘鈴。 然後， 我會再向你說明接下來要做什麼。 
2. 指導語 階段二 
現在你再做一次同樣的， 非常簡單地， 看到交通工具， 就用左手按下黃色的鍵，  
看到動物， 就用右手按下藍色的鍵。 
不同之前的是， 現在有時候在圖片之前會出現一隻手， 看到手的時候， 不論接下來的圖片
是什麼， 你都不應該再按鍵。 
3. 提問 
你可以向我簡短的說明， 現在你應該做什麼嗎?  
4. 指導語 
很好，現在你的任務是: 
看到交通工具按黃鍵， 看到動物按藍鍵， 在手後面出現的圖片， 不要按鍵。 
當鐘鈴在螢幕上出現時， 我們會有一個短暫的休息。 
然後我會再向你說明， 接下來要做什麼。 
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5. 指導語 階段三 
接下來的會較困難， 要交換按鍵。 
現在看到交通工具時， 用右手按下藍色的鍵。 看到動物時， 用左手按下黃色的鍵。 
現在你就照著這樣做， 直到螢幕上出現鐘鈴， 然後我會再向你說明， 接下來要做什麼。 
6. 指導語 階段四 
現在你再做一次同樣的， 非常簡單， 看到交通工具， 用右手按藍鍵， 看到動物， 用左手按
黃鍵。 
不同的是， 現在手會再次出現，看到手的時候， 不論接下來的圖片是什麼， 你都不應該再
按鍵。 
7. 問題 
你可以向我簡短的說明， 現在你應該做什麼嗎?  
8. 指導語 
很好，現在你的任務是: 
看到交通工具， 按藍鍵， 看到動物， 按黃鍵， 在手後面出現的圖片， 不要按鍵。 
當鐘鈴在螢幕上出現時， 這個遊戲就結束了。 
9. 結束 
在第一次的測驗之後，  
1. 感謝他/她的參與! 
 
在第二次的測驗之後，  
1. 詢問 M-Check  
2. 給受試者 500 元 
3. 感謝他/她的參與! 
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Task Stimuli 
Animals 
 
 
Transportation Vehicles 
 
124 
Stop Sign-Hand 
 
 
Bell 
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Child Behavior Checklist – Parent Form 
以下為行為的敘述，請以您的孩子目前或最近六個月的行為表現，圈選最符合他的答案。 
     
不符合 部分符合 相當符合   
0 1 2 □1  表現得比他的實際年齡小 
0 1 2 □2  好爭辯 
0 1 2 □3  好吹牛、自誇 
0 1 2 □4  不能長時間集中注意力 
0 1 2 □5  無法停止想有些事情；強迫性思考 
0 1 2 □6  坐不住、靜不下來，或活動量過高 
0 1 2 □7  黏著大人或太依賴 
0 1 2 □8  抱怨孤獨、寂寞 
0 1 2 □9  思想、語言雜亂，或看起來頭腦不清的樣子 
0 1 2 □10 好哭 
0 1 2 □11 待人殘忍或卑賤、欺負弱小 
0 1 2 □12 好做白日夢或沉溺於自己的思想中 
0 1 2 □13 太要求別人的注意 
0 1 2 □14 破壞自己的東西 
0 1 2 □15 破壞家人或同伴的東西 
0 1 2 □16 在家裡不守規矩 
0 1 2 □17 在學校不守規矩 
0 1 2 □18 不能跟其他小朋友和好相處 
0 1 2 □19 犯錯後好像沒有罪惡感 
0 1 2 □20 善妒 
0 1 2 □21 怕自己可能會想或做不對的事 
0 1 2 □22 覺得自己可能必須完美無缺 
0 1 2 □23 覺得或抱怨沒有人愛他 
0 1 2 □24 覺得別人對他有敵意 
0 1 2 □25 自卑或覺得自己沒有價值 
0 1 2 □26 常打架 
0 1 2 □27 常被嘲笑 
0 1 2 □28 常跟惹禍的同伴在一起 
0 1 2 □29 聽到不存在的聲音 
0 1 2 □30 衝動或不經考慮即行動 
0 1 2 □31 喜歡獨處 
0 1 2 □32 會說謊或欺騙 
0 1 2 □33 神經質、容易緊張 
0 1 2 □34 出現緊張性動作或抽筋 
0 1 2 □35 不被其他小孩喜歡 
0 1 2 □36 過度害怕或焦慮 
0 1 2 □37 覺得頭暈 
0 1 2 □38 有過度的罪惡感 
0 1 2 □39 過度疲倦 
0 1 2 □40 體重過重 
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不符合 部分符合 相當符合   
0 1 2 □41 退縮不和別人相處 
0 1 2 □42 擔心、煩惱 
   □43 有以下找不出生理原因的病痛 
0 1 2  a. 疼痛 
0 1 2  b. 頭痛 
0 1 2  c. 想吐，覺得身體不舒服 
0 1 2  d. 與眼睛有關的問題 
0 1 2  e. 發疹或其他皮膚方面的問題 
0 1 2  f. 胃吐或常說肚子痛 
0 1 2  g. 嘔吐 
0 1 2 □44 用身體攻擊他人 
0 1 2 □45 功課不好 
0 1 2 □46 動作協調不好或笨拙 
0 1 2 □47 特別喜歡和年紀較大的孩子玩 
0 1 2 □48 特別喜歡和年紀較小的孩子玩 
0 1 2 □49 拒絕說話 
0 1 2 □50 不斷重複某些動作；強迫性行為 
0 1 2 □51 離家出走 
0 1 2 □52 常大聲尖叫 
0 1 2 □53 喜歡保守秘密，不希望別人知道他的事 
0 1 2 □54 看到不存在的東西 
0 1 2 □55 敏感、容易受窘 
0 1 2 □56 縱火 
0 1 2 □57 好賣弄或好扮小丑 
0 1 2 □58 害羞或膽小 
0 1 2 □59 發呆 
0 1 2 □60 在家裡偷東西 
0 1 2 □61 在外面偷東西 
0 1 2 □62 怪異的行為 
0 1 2 □63 怪異的念頭 
0 1 2 □64 倔強固執、悶悶不樂、煩躁易怒 
0 1 2 □65 情緒突然地轉變 
0 1 2 □66 常鬧彆扭 
0 1 2 □67 多疑 
0 1 2 □68 咒罵或說髒話 
0 1 2 □69 太多話或愛說話 
0 1 2 □70 常嘲笑別人 
0 1 2 □71 脾氣暴躁 
0 1 2 □72 太常想到性 
0 1 2 □73 恐嚇他人 
0 1 2 □74 曠課逃學 
0 1 2 □75 活動量低、動作緩慢，或無精打采 
0 1 2 □76 不快樂、悲傷，或沮喪 
0 1 2 □77 說話異常大聲 
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不符合 部分符合 相當符合   
0 1 2 □78 非醫療用途而使用酒精、興奮劑或麻醉品 
0 1 2 □79 有破壞物品的行為 
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SNAP-IV – Parent Form 
請選擇一個代碼，最能表達在過去的一個星期中，您的孩子的狀況。 
 
完
全 
沒
有 
有一
點點 
還算
不少 
非常
的多 
 
0 1 2 3 □1  無法專注於細節的部份，或在做學校作業或其他的活動
時，出現粗心的錯誤 
0 1 2 3 □2  很難持續專注於工作或遊戲活動 
0 1 2 3 □3  看起來好像沒有在聽別人對他（她）說話的內容 
0 1 2 3 □4  沒有辦法遵循指示，也無法完成學校作業或家事 (並不是
由於對立性行為或無法了解指示的內容) 
0 1 2 3 □5  組織規劃工作及活動有困難 
0 1 2 3 □6  逃避，或表達不願意，或有困難於需要持續性動腦的工作
(例如學校作業或是家庭作業)  
0 1 2 3 □7  會弄丟工作上或活動所必需的東西 (例如 學校作業，鉛
筆，書，工具，或玩具) 
0 1 2 3 □8  很容易受外在刺激影響而分心 
0 1 2 3 □9  在日常生活中忘東忘西的 
0 1 2 3 □10 在座位上玩弄手腳或不好好坐著 
0 1 2 3 □11 在教室或是其他必須持續坐著的場合，會任意離開座位 
0 1 2 3 □12 在不適當的場合，亂跑或爬高爬低 
0 1 2 3 □13 很難安靜地玩或參與休閒活動 
0 1 2 3 □14 總是一直在動或是像被馬達所驅動 
0 1 2 3 □15 話很多 
0 1 2 3 □16 在問題還沒問完前就急著回答 
0 1 2 3 □17 在遊戲中或團體活動中，無法排隊或等待輪流 
0 1 2 3 □18 打斷或干擾別人 (例如 插嘴或打斷別人的遊戲) 
0 1 2 3 □19 發脾氣 
0 1 2 3 □20 與大人爭論 
0 1 2 3 □21 主動地反抗或拒絕大人的要求或規定 
0 1 2 3 □22 故意地做一些事去干擾別人 
0 1 2 3 □23 因自己犯的錯或不適當的行為而怪罪別人 
0 1 2 3 □24 易怒的或很容易被別人激怒 
0 1 2 3 □25 生氣的及怨恨的 
0 1 2 3 □26 惡意的或有報復心的 
 
